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Mindfulness-based interventions targeting psychological and physical symptoms 
in cancer survivors have been shown to be efficacious.  However, little is known about 
theory-based psychological processes through which mindfulness-based interventions 
may decrease symptoms.  The present study is a secondary analysis of data from a 
mindfulness-based stress reduction (MBSR) pilot trial targeting cancer-related fatigue 
(CRF) in cancer survivors.  Thirty-five persistently fatigued cancer survivors were 
recruited from a university hospital and various community clinics in Indianapolis, 
Indiana.  Participants were randomized to either a 7-week MBSR intervention for CRF or 
a waitlist control (WC) condition.  Measures were administered at pre-intervention, post-
intervention, and 1-month follow-up and included levels of mindfulness, acceptance, and 
self-compassion as well as the symptom outcomes of fatigue interference, sleep 
disturbance, and distress.  I hypothesized that MBSR would lead to increased levels of 
five facets of mindfulness (i.e., observing, describing, acting with awareness, nonjudging 
of inner experience, nonreactivity to inner experience), self-compassion, and acceptance 
as compared to the WC condition.  Using a linear mixed modeling approach, significant 
group by time interactions were only found for observing, acting with awareness, 
nonjudging, and self-compassion, such that the MBSR group showed steady increases in 
these processes over time, whereas the WC group’s scores remained relatively stable.  In 
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addition, I examined whether positive changes in the five facets of mindfulness were 
associated with reductions in the three symptoms using multiple linear regression.  This 
hypothesis was partially supported; acting with awareness was the only facet of 
mindfulness to show a modest association with a decrease in fatigue, but this result fell 
short of statistical significance.  In addition, decreased sleep disturbance was predicted by 
increases in acting with awareness and nonjudging, while decreased distress was 
predicted by increases in observing, acting with awareness, nonjudging, and 
nonreactivity.  Results point to specific psychological processes that may be targeted to 
maximize the efficacy of future MBSR interventions for cancer survivors.  
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CHAPTER 1. INTRODUCTION 
Cancer survivors often experience physical and psychological symptoms for 
months or even years following treatment (Hofman, Ryan, Figueroa-Moseley, Jean-
Pierre, & Morrow, 2007; Prue, Rankin, Allen, Gracey, & Cramp, 2006).  Some of the 
most common symptoms are fatigue, sleep disturbance, depression, and anxiety, and, for 
some, these symptoms interfere with daily activities and cannot be relieved with medical 
therapies (Berger, Gerber, & Mayer, 2012; Minton et al., 2013).  As evidence for 
psychosocial interventions for cancer survivors’ symptoms has been growing, the focus 
on mindfulness-based therapies has increased (Bower, 2014; Faller et al., 2013).  
However, theory-based psychological processes through which mindfulness-based 
therapies, particularly mindfulness-based stress reduction (MBSR), may decrease 
symptoms have received limited attention.  The present study examined several key 
psychological processes through which MBSR is hypothesized to influence symptoms, 
including mindfulness, acceptance, and self-compassion. 
First, I will discuss common symptoms in cancer populations, including cancer-
related fatigue, sleep disturbance, and anxiety and depressive symptoms, and available 
treatments for these symptoms.  I will then review the literature on mindfulness-based 
interventions for these symptoms and provide a rationale for examining potential 
psychological processes underlying MBSR’s effects on symptoms.  Finally, I will present 
my hypotheses and study methods and discuss the results and their implications. 
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Cancer-related Fatigue, Sleep Disturbance, and their Treatment in Cancer 
Populations 
Cancer-related Fatigue 
Cancer-related fatigue (CRF) is one of the most common symptoms experienced by 
cancer patients and survivors (Hofman et al., 2007; Prue et al., 2006).  It may be present 
before, during, and after treatment, with some survivors experiencing CRF for months or 
even years post-treatment (Hofman et al., 2007).  CRF is frequently reported as the most 
distressing symptom and interferes with daily functioning even more so than pain (Curt, 
2000).  It is also strongly linked to several negative outcomes, including increased 
depressive symptoms and anxiety, increased disability, and decreased work productivity 
and engagement in social activities (Bower et al., 2000; Curt, 2000; Hann et al., 1998).  
While there is no consensus regarding the definition of CRF, the National 
Comprehensive Cancer Network (NCCN) defines CRF as “a distressing, persistent, 
subjective sense of physical, emotional and/or cognitive tiredness or exhaustion related to 
cancer or cancer treatment that is not proportional to recent activity and interferes with 
usual functioning” (National Comprehensive Cancer Network, 2015, p. 5).  CRF is 
different from fatigue experienced by healthy individuals in that it is not typically 
relieved with increased rest and sleep (Ryan et al., 2007).   
Prevalence rates for CRF have varied due to different screening measures and 
definitions of the symptom.  In a review by Donovan and colleagues (2013), prevalence 
rates for CRF in patients and survivors ranged from 9.2% to 56% when using diagnostic 
criteria from the Fatigue Coalition.  In a study of 814 cancer patients receiving 
chemotherapy and/or radiotherapy, 80% experienced CRF (Henry et al., 2008).  
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Prevalence rates for CRF in cancer patients who have completed treatment are typically 
lower and range from 21% to 53% (Cella, Davis, Breitbart, & Curt, 2001; Knobel et al., 
2001).  Fatigue often persists for years after cancer treatment (Bower et al., 2006).  For 
example, in a longitudinal study of 763 disease-free breast cancer survivors at 5-10 years 
post-diagnosis, 34% reported significant fatigue, which is equivalent to prevalence rates 
at 1-5 years post-diagnosis (Bower et al., 2006).  Because of the high prevalence and 
distressing nature of CRF, the American Society of Clinical Oncology (ASCO) has 
recommended that all cancer patients be evaluated for the presence of fatigue after 
completion of primary treatment and be offered specific information and strategies for 
fatigue management (Bower, Bak, et al., 2014). 
Sleep Disturbance 
Sleep disturbance, defined as perceived or actual disruptions in nighttime sleep or 
daytime wakefulness, is another prevalent symptom experienced by cancer patients and 
survivors and is associated with greater fatigue and depression, which negatively affect 
quality of life (Otte, Carpenter, Russell, Bigatti, & Champion, 2010; Palesh et al., 2010).  
Sleep disturbance can include a variety of sleep disorders, such as insomnia, restless legs 
syndrome, and sleep apnea (Otte et al., 2010).  In one of the largest survey studies on 
sleep disturbances in cancer patients (n = 982), the most prevalent problems were 
excessive fatigue (44%), leg restlessness (41%), insomnia (31%), and excessive 
sleepiness (28%) (J. R. Davidson, MacLean, Brundage, & Schulze, 2002).   
One of the most prevalent and distressing sleep disorders in cancer populations is 
insomnia/insomnia syndrome, which is defined as difficulty falling asleep or staying 
asleep (wake episodes for >30 minutes in the middle of the night), early awakening 
4 
 
(waking 30 minutes before intended), or non-restorative sleep (Palesh et al., 2010).  
Prevalence rates for insomnia are 36% to 43% for cancer patients on active treatment, 
and 30% for patients with no recent treatment (J. R. Davidson et al., 2002; Palesh et al., 
2010; J. Savard & Morin, 2001; J. Savard, Simard, Blanchet, Ivers, & Morin, 2001).  
Cancer patients’ rates of insomnia and other sleep disturbances exceed those found in 
non-cancer populations, with problems reported in about 30% to 87% of cancer patients 
(J. Savard et al., 2001) compared to 16% to 20% in the general population (Ohayon, 
2002).  For example, in a prospective study of 823 patients of mixed cancer types 
undergoing chemotherapy, 43% met clinical criteria for insomnia after their first cycle, 
which is nearly three times higher than the rate in the general population, and an 
additional 37% of patients reported subclinical levels of insomnia symptoms (Palesh et 
al., 2010).  Furthermore, in a study comparing long-term breast cancer survivors who 
were at least 2 years post-treatment to age-matched women without a breast cancer 
history, survivors had significantly more sleep disturbances and worse sleep quality (Otte 
et al., 2010).   
Due to the strong association between fatigue and sleep disturbance, ASCO has 
included assessment and treatment of sleep disturbance, among other contributing factors, 
in guidelines for treating fatigue in cancer populations (Bower, Bak, et al., 2014).  The 
NCCN also recommends screening for sleep disorders in cancer survivors at regular 
intervals and providing different treatment options or referrals to sleep specialists when 
necessary (National Comprehensive Cancer Network, 2016). 
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Treatments for Cancer-related Fatigue and Sleep Disturbance 
Treatments for CRF and sleep disturbance have included pharmacologic as well 
as psychosocial interventions.  Evidence supporting the use of psychostimulants for 
fatigue following cancer therapy has been mixed (Minton, Richardson, Sharpe, Hotopf, & 
Stone, 2008).  A meta-analysis of four methylphenidate trials and one dexamphetamine 
trial with advanced stage cancer patients (n = 426), most of whom were not receiving 
active cancer treatment, found that psychostimulants were on average significantly more 
effective compared to a placebo (d = -0.28), but four of the trials did not show significant 
differences between the groups (Minton, Richardson, Sharpe, Hotopf, & Stone, 2011).  
Modafinil is another stimulant tested for the treatment of CRF.  A trial with 631 patients 
undergoing chemotherapy demonstrated that modafinil had some benefit for patients with 
severe fatigue, but not for patients with mild or moderate fatigue (Jean-Pierre et al., 
2010).  Furthermore, psychostimulants such as modafinil may produce adverse effects 
with long-term use, especially among older cancer patients (Minton et al., 2008).   
Pharmacologic interventions for sleep disturbance in cancer patients have even 
more limited empirical support and have been associated with various risks, including 
anaphylaxis, angioedema, and complex sleep-related behaviors, such as sleep-driving 
(Food and Drug Administration, 2007).  The NCCN noted several prescribing 
considerations when treating cancer patients’ sleep disturbance, including withdrawal 
symptoms, dependency, and increased potential for drug interactions (National 
Comprehensive Cancer Network, 2015). 
A larger literature has focused on psychosocial and activity-based interventions 
for addressing CRF and associated symptoms.  Kangas and colleagues (2008) conducted 
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a meta-analysis of 41 psychosocial and 16 exercise intervention studies enrolling 4,621 
cancer patients and found a significant small to moderate effect size (d = -.31) on CRF 
across all studies.  The effect size did not significantly differ between psychosocial and 
exercise interventions.  Another meta-analysis of 18 psychosocial and 12 activity-based 
interventions for CRF found a small effect size (d = .09) across all studies, and a 
significantly larger effect size for psychosocial studies (d = .10) compared to exercise 
studies (d = .05) (Jacobsen, Donovan, Vadaparampil, & Small, 2007).  The authors also 
reported that 50% of psychological trials and 44% of exercise trials had significantly 
greater effects on CRF in their respective intervention groups when compared to the 
control group.  However, the evidence remains limited due to the failure to include CRF 
as an enrollment criterion in many studies.  Overall, evidence for the psychosocial 
treatment of fatigue has been moderate to strong, leading the NCCN to make a category 1 
recommendation for psychosocial intervention, including MBSR, for fatigue in cancer 
survivors (National Comprehensive Cancer Network, 2015).  A category 1 
recommendation is made when the NCCN reaches a uniform consensus based on high-
level evidence.   
Psychosocial interventions have also been examined for sleep disorders in cancer 
populations.  Cognitive-behavioral therapy for insomnia (CBT-I), which involves sleep 
restriction, stimulus control, sleep hygiene, cognitive restructuring, and relaxation 
training, is one of the more commonly tested interventions.  A recent meta-analysis of 8 
studies with 752 cancer survivors found that the CBT-I condition produced medium-sized 
effects on sleep efficiency (d = 0.53), sleep latency (d = 0.43), and wake time after sleep 
onset (d = 0.41) compared to control conditions (Johnson et al., 2016).  Large effect sizes 
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were also found for self-reported insomnia (d = 0.77).  Overall, the strength of the 
evidence has led the NCCN to make a category 1 recommendation for CBT-I (National 
Comprehensive Cancer Network, 2015). 
Distress and its Treatment in Cancer Populations 
Distress 
During and after cancer treatment, many patients and survivors also experience 
anxiety and depressive symptoms related to cancer treatment, concerns about recurrence, 
adjustment to daily living following treatment, and many other cancer-related 
experiences.  Research has found that rates of depressive disorders in cancer patients in 
primarily inpatient settings range from 10% to 25%, which is about four times greater 
than the general population and comparable to the rate identified in other populations 
with chronic physical illnesses (Carr et al., 2002; Pirl, 2004).  Another study of a 
representative sample of 1,323 cancer survivors at six months post-diagnosis found that 
24% had elevated anxiety, 14% had elevated depressive symptoms, and 10% had 
elevated anxiety and depressive symptoms on the Hospital Anxiety and Depression Scale 
(Boyes, Girgis, D’Este, & Zucca, 2011).  A recent meta-analysis of 211 studies assessing 
self-reported depressive symptoms in cancer patients during and after treatment found an 
8% to 24% pooled prevalence of depression, defined as meeting DSM or ICD criteria or 
clinical cutoffs on self-report measures of depressive symptoms (Krebber et al., 2014).  
Depressive symptoms and anxiety in cancer patients have been linked to poorer quality of 
life, increased health care costs, and more physical symptoms such as pain, insomnia, and 
fatigue if the psychological symptoms are not adequately addressed (Andersen et al., 
2014; Trudel-Fitzgerald, Savard, & Ivers, 2013).  Given the high prevalence of mood 
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disturbance in cancer populations, ASCO has recommended that all cancer patients be 
evaluated for depression and anxiety at multiple time points of care so that providers may 
intervene (Andersen et al., 2014).   
Treatment of Distress 
Research supports the use of both psychosocial and pharmacologic interventions 
for  distress in cancer populations (Hart et al., 2012; Li, Fitzgerald, & Rodin, 2012).  
Laoutidis and Mathiak (2013) conducted a meta-analysis of six antidepressant 
randomized controlled trials (RCTs) (N = 563 cancer patients) and found that, compared 
to placebo controls, antidepressants had a large effect size (d = 1.56).  In addition, a meta-
analysis of 198 psychological intervention trials (N = 22,238 cancer patients) addressing 
emotional distress and health-related quality of life (i.e., a global construct including 
depression, anxiety, and somatic complaints) found significant small-to-medium effects 
for psychotherapy and psychoeducation compared to controls (Faller et al., 2013).  
However, when analyzing the subset of studies with a distress criterion for enrollment, 
there were large effects for general emotional distress (d = 1.01) and quality of life (d = 
0.89) and medium effects for anxiety (d = 0.56) and depression (d = 0.53).  A systematic 
review of 14 meta-analyses of psychosocial interventions for cancer populations found 
that having a distress criterion for eligibility led to psychological treatment effects three 
times as large as those found in trials with no distress criterion (Linden & Girgis, 2012). 
When examining specific psychological therapies, a meta-analysis of 15 studies 
enrolling 1,492 adult cancer survivors found that cognitive-behavioral therapy (CBT) had 
large effects on depression (d=1.20), anxiety (d = 1.99), and quality of life (d = 0.91) 
post-intervention as well as significant effects on quality of life at follow-up time points 
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<8 months and >8 months post-intervention (d = 1.45 and d = 0.26, respectively) 
compared to control groups, but these effects were not sustained at follow-up (Osborn, 
Demoncada, & Feuerstein, 2006).  In subgroup analyses of six psychotherapeutic and 
four pharmacologic RCTs with elevated depressive symptoms as an enrollment criterion, 
CBT appeared to be more effective than problem-solving therapy (p < .001), but not more 
effective than pharmacologic intervention (p = .07) (Hart et al., 2012).  Although the 
evidence for psychosocial interventions is strong, with specific forms of therapy having 
more empirical support than others, many patients do not benefit from CBT or other 
standard therapies and may be more responsive to mindfulness-based interventions. 
Theory of MBSR 
MBSR is a well-studied mindfulness-based intervention with origins in Buddhist 
philosophy and has been used to treat physical and psychological symptoms.  The theory 
of MBSR has a core maxim to reduce human suffering by cultivating flexibility in 
participants’ attention and attitude towards undesirable experiences (Kabat-Zinn, 1990).  
Suffering from either psychopathology or medical pathology is thought to be rooted in 
experiential avoidance, which refers to attempts to control the undesirable symptom or 
experience (Hayes, Strosahl, & Wilson, 1999).  Efforts to control unwanted experiences 
by fighting or avoiding them can lead to the loss of activities of value and meaning.  This 
maladaptive approach to life’s uncomfortable circumstances is targeted in MBSR by 
fostering greater psychological flexibility, which has been defined as the ability to remain 
fully present to emotions, thoughts, and sensations while engaging in activities consistent 
with personal values (Hayes, Luoma, Bond, Masuda, & Lillis, 2006). 
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The present trial was grounded in an MBSR framework, positing that survivors 
with CRF may have debilitating fears that result in experiential avoidance affecting 
valued activities.  The examined MBSR intervention sought to decrease experiential 
avoidance by increasing psychological flexibility.  Specifically, the intervention targeted 
three interrelated components of psychological flexibility: acceptance, mindfulness, and 
self-compassion. 
The first of these components is acceptance--a primary target for intervention as it 
is the opposite of experiential avoidance.  Acceptance refers to permitting an internal or 
external experience to be as it is with no attempts to control or change it (Hayes, Wilson, 
Gifford, Follette, & Strosahl, 1996).  Acceptance also refers to recognition of one’s own 
tendencies to evaluate experiences and the belief that judging, controlling, or avoiding 
them are not helpful.  This perspective leads to change in responses to unwanted 
experiences by directing one’s focus to actions that promote personal goals and values. 
Another component of psychological flexibility is mindfulness, which is 
commonly defined as intentionally attending to the present moment without judging that 
experience as either positive or negative (Baer, 2011; Kabat-Zinn, 1994).  With 
mindfulness, any experiences that enter awareness are noticed and recognized as fleeting, 
not as unwanted experiences that should be avoided or eliminated (Kabat-Zinn, 1994). 
Researchers have conducted confirmatory and exploratory analyses with existing 
mindfulness questionnaires and concluded that mindfulness has multiple dimensions.  
One common definition of mindfulness includes five facets: (1) observing, which refers 
to noticing and attending to experiences in and outside of oneself, (2) describing, which 
refers to labeling internal experiences with words, (3) acting with awareness, which 
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involves purposeful attention to one’s present activities, (4) nonjudging of inner 
experience, which refers to taking a nonevaluative stance toward thoughts and feelings, 
and (5) nonreactivity to inner experience, which refers to the tendency to allow thoughts 
and feelings to come and go without being caught up in them (Baer et al., 2008).  
Examination of each facet is common in research studies, although some research 
supports the use of a general overarching mindfulness construct (Carmody & Baer, 
2008).  To date, research has not determined whether there is a temporal element in the 
development of mindfulness facets.   
A third component of psychological flexibility is self-compassion.  Research has 
suggested that self-compassion includes three aspects: (1) self-kindness, defined as 
“being kind and understanding toward oneself in instances of pain or failure rather than 
being harshly self-critical,” (2) common humanity, or “perceiving one’s experience as 
part of the larger human experience rather than seeing them as isolating,” and (3) 
“holding painful thoughts and feelings in balanced awareness rather than over-identifying 
with them” (Neff, 2003, p.89).  These three components are thought to enhance one 
another.  Having self-compassion has also been described as similar to feeling 
forgiveness towards oneself, or perceiving one’s suffering as part of the human condition 
and acknowledging its worth (Neff, 2003b).  By approaching unwanted experiences with 
this attitude, non-judgment and associated reductions in experiential avoidance are easier 
to achieve.   
Mindfulness-based Interventions 
Mindfulness-based interventions have been employed in a large number of trials 
targeting physical and psychological symptom outcomes.  The standard MBSR course 
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has been adapted for various medical and psychiatric conditions, and other related 
interventions have been tested, including mindfulness-based cognitive therapy (MBCT), 
dialectical behavior therapy, yoga, and acceptance and commitment therapy (ACT) 
(Cramer, Lange, Klose, Paul, & Dobos, 2012; Hulbert-Williams, Storey, & Wilson, 2014; 
Zainal, Booth, & Huppert, 2013).   
Standard MBSR Course 
MBSR is a teacher-facilitated course developed by Jon Kabat-Zinn at the 
University of Massachusetts Medical Center in 1979.  MBSR is based on the idea that 
cultivating mindfulness, or paying attention on purpose to the present moment with 
compassion and open-hearted curiosity, can lead to fuller participation in life (Kabat-
Zinn, 1994).  It was first tested with participants dealing with general stress, pain, and 
illness and was then adapted to patients with specific medical and psychiatric conditions 
and symptoms (Carlson, 2012; Kabat-Zinn, 1990).   The standard MBSR course 
comprises eight weekly 2.5-hour classes and a day-long retreat.  The curriculum includes 
experiential meditation practices, group discussion, and education on stress reactivity, 
stress physiology, and basic neurobiology.  Participants are also given daily home 
practice assignments to complete with the help of guided meditation recordings. 
Meditation is a core component of the MBSR course, with various meditation 
practices introduced during the classes.  Participants are first taught fundamental 
elements of meditation, including mindful breathing exercises and the sitting meditation, 
which emphasizes postures and incorporates aspects of the breathing exercises.  
Awareness of the body and noticing but not judging internal experiences, such as 
thoughts, are taught through these practices.  After simply noticing thoughts, participants’ 
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focus is then redirected to the breath and current meditation.  These ideas are extended in 
the gentle mindful yoga and mindful walking practices.  Attentional practice is a target of 
these exercises, and participants learn to acknowledge both internal and external cues, 
such as bodily sensations and environmental distractions, without judging them.  
Gradually, participants learn to further apply these practices to situations in their daily 
lives.  Participants are also provided with opportunities to clarify and review the 
meditation practices, discuss didactics on the mind-body relationship, and share their 
progress with one another. 
Efficacy of MBSR and Mindfulness-based Interventions 
Numerous studies have been conducted since the inception of MBSR 
demonstrating the effectiveness of mindfulness training for a wide range of conditions 
and symptoms, including stress, pain, depression, anxiety, and sleep (Chiesa & Serretti, 
2009; Grossman, Niemann, Schmidt, & Walach, 2004; Hofmann, Sawyer, Witt, & Oh, 
2010; Veehof, Oskam, Schreurs, & Bohlmeijer, 2011; Winbush, Gross, & Kreitzer, 
2007).  In a narrative review of mindfulness-based interventions, Carlson and colleagues 
(2012) evaluated their efficacy for populations with cancer, chronic pain, low back pain, 
fibromyalgia, rheumatoid arthritis, cardiovascular disease, diabetes, HIV/AIDS, irritable 
bowel syndrome, and organ transplant.  For nearly all of these conditions, level 1 or 2 
evidence for efficacy in reducing a variety of symptoms was found, with some conditions 
such as cancer having much stronger level 1 evidence for psychological, functional, and 
quality-of-life outcomes compared to evidence for other chronic conditions.  Level 1 
indicates the highest level of evidence, with at least one systematic review or meta-
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analysis conducted on RCTs, while level 2 refers to evidence from RCTs with a usual 
care, waitlist, or active comparison group (Merlin, Weston, & Tooher, 2009).   
An earlier meta-analysis examined the effects of MBSR on various health 
outcomes of both clinical and non-clinical populations in 20 studies, of which 13 were 
RCTs (Grossman et al., 2004).  In five controlled trials (N= 203 participants) with 
physical symptom outcomes, there was a medium effect size for physical health (d = 
0.53).  In 11 controlled trials (N = 771 participants) examining psychological outcomes, 
there was also a medium effect size for mental health (d = 0.54).  Similarly, a recent 
meta-analysis of 209 studies on mindfulness-based therapies for people with physical and 
psychological conditions as well as non-clinical populations found moderate effect sizes 
for the targeted physical or psychological outcome in pre-post comparisons (Hedges’ g = 
.55) and comparisons to waitlist controls (Hedges’ g = .53) or active controls (Hedges’ g 
= .33) (Khoury et al., 2013).  Overall, these results suggest that MBSR can improve a 
range of physical and mental health outcomes in clinical and non-clinical samples. 
Research on mindfulness-based interventions adapted to the cancer context has 
been rapidly growing in the last decade.  Several recent meta-analyses and clinical trials 
involving mindfulness-based interventions have demonstrated positive results with 
respect to physical and psychological health outcomes in cancer patients (Ledesma & 
Kumano, 2009; Musial, Bussing, Heusser, Choi, & Ostermann, 2011; Piet, Würtzen, & 
Zachariae, 2012; Shennan, Payne, & Fenlon, 2011; Zainal et al., 2013).  For example, a 
meta-analysis of nine studies examining the effects of MBSR on the mental health of 
breast cancer patients found promising results (Zainal et al., 2013).  Examined studies 
included two RCTs, a quasi-experimental case-control study, and one group pre-post 
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intervention studies.  There were medium effect sizes for MBSR on stress (d = 0.71), 
depression (d = 0.58), and anxiety (d = 0.73).  These findings suggest moderate effects of 
MBSR on the mental health of breast cancer patients, although the study designs limit the 
conclusions that may be drawn.  
Similar positive evidence has been found in mindfulness-based RCTs for patients 
with other types of cancer.  For example, a meta-analysis of nine high-quality RCTs of 
MBSR and MBCT targeting anxiety and depression in cancer patients and survivors of 
various disease types and stages (n = 955) found effects for anxiety (Hedges’ g = 0.37) 
and depression (Hedges’ g = 0.44)  (Piet et al., 2012).  In a recent meta-analysis of seven 
mindfulness-based RCTs addressing cancer patients’ mental health outcomes (N = 469), 
reductions in anxiety and depression were found compared to control groups (pooled 
SMD = -0.75 and pooled SMD = -0.90; respectively) (Zhang et al., 2015).  Subgroup 
analyses showed that these effects varied by type of mindfulness-based therapy, with 
mindfulness-based art therapy and MBCT being more efficacious than other forms of 
mindfulness-based therapy.  Another meta-analysis examined the effects of four MBSR 
RCTs and six single-group, pre- and post-test MBSR studies and found that MBSR had a 
medium effect (d = .48) on the mental health of cancer patients and a small effect (d = 
0.18) on physical health, which included self-reported physical functioning as well as 
biological markers of general health (Ledesma & Kumano, 2009). 
Recent primary studies have also demonstrated the impact of mindfulness-based 
interventions on a variety of psychological and physical health outcomes in cancer 
patients and survivors.  Hoffman and colleagues (2012) found that breast cancer patients 
who completed an 8-week MBSR course had decreased mood disturbance, endocrine 
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symptoms, and breast-related quality-of-life symptoms as compared to waitlist controls at 
post-intervention and 3-month follow-up assessments.  In another recent study, Bower 
and colleagues (2015) demonstrated that a 6-week mindfulness meditation intervention 
for younger breast cancer survivors resulted in significant reductions in perceived stress, 
proinflammatory gene expression, and levels of inflammatory biomarkers post-
intervention as compared to a waitlist control group.  Several recent studies of 
mindfulness-based interventions for cancer patients used a symptom criterion for study 
entry (Johannsen et al., 2016; Johns et al., 2015).  For example, an RCT enrolled breast 
cancer patients with significant post-treatment pain and found significant effects of 
MBCT on pain intensity and neuropathic pain compared to the waitlist control group 
(Johannsen et al., 2016).   
Although the results of new trials of mindfulness-based interventions for cancer 
populations continue to be promising, a limitation across studies is the lack of active 
control groups.  This limitation has recently received greater attention, and researchers 
are calling for more studies with active control conditions or comparators (Bower, 2016).  
New studies have started adopting this study design.  In one study comparing 
mindfulness-based cancer recovery (MBCR), an adaptation of MBSR for cancer 
populations, to supportive expressive group therapy (SET) for distressed breast cancer 
survivors, those in the MBCR group showed greater reductions in mood disturbance and 
stress symptoms, as well as increased emotional and functional quality of life, social 
support, spirituality, and post-traumatic growth compared to those in the SET group, and 
most effects were sustained at 1-year follow-up (Carlson et al., 2016).  A pilot study 
compared MBSR to psychoeducational support for CRF in breast and colorectal cancer 
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survivors who were not on active treatment and found lower levels of CRF interference 
post-intervention in the MBSR group, but this result was not statistically significant 
(Johns et al., 2016).  Those in the MBSR group also had greater improvement in vitality 
and greater reductions in pain post-intervention.   
Interventions with similar components to MBSR have also been conducted with 
cancer patients and survivors.  Yoga, which is part of the standard MBSR course, is one 
of these interventions.  In a meta-analysis of 12 yoga RCTs (N = 742 breast cancer 
patients and survivors), yoga had short-term effects on global health-related quality of 
life (Hedges’ g = 0.62), functional well-being (Hedges’ g = 0.30), social well-being 
(Hedges’ g  = 0.29), and spiritual well-being (Hedges’ g = 0.41) relative to control 
conditions (Cramer et al., 2012).  Short-term effects were also found for anxiety (Hedges’ 
g = −1.51), depression (Hedges’ g = −1.59), perceived stress (Hedges’ g = −1.14), and 
psychological distress (Hedges’ g = −0.86).  However, these results were not obtained for 
the subgroup of participants who had completed active cancer treatment, and 
methodological shortcomings of the trials were noted (e.g., possible attrition bias).  
Similar results were obtained in another meta-analysis of 10 yoga RCTs with cancer 
patients; compared to controls, the yoga groups showed greater improvement in anxiety 
(8 studies; SMD = -0.76), depression (8 studies; SMD = -0.95), distress (2 studies; SMD 
= -0.40), and stress (2 studies; SMD = -0.95) (Lin, Hu, Chang, Lin, & Tsauo, 2011). 
Another intervention with similar components and theory relative to MBSR is 
ACT.  ACT is an approach to therapy that employs a range of behavioral techniques to 
increase psychological flexibility with a focus on mindfulness and value-based action 
(Hayes et al., 2006).  A systematic review discussed promising findings from six 
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preliminary studies of ACT for cancer patients and noted the need for control groups and 
larger samples (Hulbert-Williams et al., 2014).  In one of the few controlled studies of 
ACT to date in cancer patients, late-stage ovarian cancer patients randomly assigned to 
12 sessions of ACT showed greater decreases in psychological distress and better quality 
of life post-intervention than those in a CBT condition (Rost, Wilson, Buchanan, 
Hildebrandt, & Mutch, 2012).  A 9-week ACT intervention trial with 45 cancer patients 
also found improvement in distress, mood, and quality of life at post-intervention and 3-
month follow-ups (Feros, Lane, Ciarrochi, & Blackledge, 2013).  However, there was no 
control arm in this study.   
Despite a growing body of research on mindfulness-based therapies, the effect of 
such interventions on theory-based psychological processes (e.g., mindfulness, self-
compassion) in cancer and non-cancer populations has received limited research 
attention.  In a university-based, cohort-controlled study of therapists in training, MBSR 
led to increased levels of mindfulness and self-compassion compared to control courses 
(research methods and psychological theory) (Shapiro, Brown, & Biegel, 2007).  A study 
of a community sample also found increases in self-compassion, spirituality, and 
empathic perspective-taking following a mindfulness-based intervention, but a control 
group was not employed (Birnie, Speca, & Carlson, 2010).  Another study of MBCR 
versus waitlist control for cancer patients at varying stages of disease and treatment found 
that MBCR led to increased levels of mindfulness (Labelle, Campbell, Faris, & Carlson, 
2015).   
Although mindfulness has been assessed as an outcome of some mindfulness-
based intervention trials (Labelle et al., 2015; Shapiro et al., 2007), limited research has 
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linked changes in mindfulness and related processes during the intervention period to 
physical or psychological symptom improvement.  A study of MBSR versus waitlist 
control in a non-clinical population found that mindfulness mediated MBSR’s impact on 
difficulties in emotional regulation and fear of emotion (Keng, Smoski, Robins, Ekblad, 
& Brantley, 2012).  A meta-analysis of mediation studies on MBSR and MBCT in all 
populations (ns = 6-12 studies across outcomes) demonstrated that mindfulness, 
rumination, and worry mediated the interventions’ effects on mental health outcomes 
(e.g., depression, anxiety, stress, distress, and negative affectivity) and did not find 
sufficient evidence for links between self-compassion and acceptance and these outcomes 
(Gu, Strauss, Bond, & Cavanagh, 2015).  However, methodological shortcomings of the 
included studies were noted, such as lack of randomization in some studies and 
publication bias.     
A few intervention studies have examined links between changes in psychological 
processes, including mindfulness, and symptom outcomes in cancer populations.  In one 
study of cancer patients, increased levels of mindfulness following participation in an 8-
week MBSR course were related to reduced stress and mood disturbance (Garland, 
Tamagawa, Todd, Speca, & Carlson, 2013).  Several trials testing an MBSR course 
compared to a waitlist control condition for cancer patients found that that increased 
mindfulness mediated the effect of MBSR on psychological outcomes, including 
decreased perceived stress, exhaustion, and posttraumatic avoidance symptoms and 
increased positive affect, quality of life, spirituality, and posttraumatic growth 
(Bränström, Kvillemo, Brandberg, & Moskowitz, 2010; Labelle, Lawlor-Savage, 
Campbell, Faris, & Carlson, 2014).  Additionally, a recent study of a mindfulness 
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meditation intervention for breast cancer survivors as compared to a waitlist control 
condition found that the intervention led to decreased depressive symptoms, which was 
mediated by increased self-kindness (a component of self-compassion), increased 
mindfulness, and decreased rumination (Boyle et al., 2017).  However, another study of 
MBSR versus a waitlist control condition for cancer patients demonstrated that increased 
mindfulness did not mediate the effects of MBSR on depressive symptoms, and the effect 
was instead attributed to decreased rumination (Labelle, Campbell, & Carlson, 2010).  
The limited and mixed findings suggest a need for additional research to elucidate 
relationships between psychological processes and clinical outcomes of MBSR for cancer 
populations. 
Theory suggests that mindfulness may impact symptom experiences because non-
judgmental attention to the present moment may result in reperceiving, or a significant 
shift in perspective (Shapiro, Carlson, Astin, & Freedman, 2006).  This shift may 
interrupt automatic, maladaptive reactions to unwanted internal experiences.  Shapiro and 
colleagues (2006) theorized that reperceiving anxiety, for example, allows one to step 
back from it and view it as an emotional state that will pass with time.  Mindfulness is 
also hypothesized to impact symptom experiences by decreasing rumination (Coffey, 
Hartman, & Fredrickson, 2010), or repetitive and negative thoughts about symptoms that 
do not lead to problem-solving (Nolen-Hoeksema, Wisco, & Lyubomirsky, 2008) and 
may exacerbate depressive and anxiety symptoms (Nolen-Hoeksema, 2000).   
Theory suggests that mindfulness also may be related to several physiological 
processes associated with symptom reduction (Creswell & Lindsay, 2014; Lazar et al., 
2000).  One theory proposes that mindfulness is linked to a physiological relaxation 
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response that leads to reduced somatic symptoms (Carlson & Garland, 2005; Lazar et al., 
2000).  Another related theory suggests that mindfulness is negatively associated with the 
stress reactivity response, which triggers exacerbation of disease pathogenic processes in 
depression, HIV, cardiovascular disease, and cancer, and encourages unhealthy behaviors 
that may affect health outcomes (Creswell & Lindsay, 2014).  In support of this theory, 
neuroimaging studies conducted with non-clinical populations have shown that both trait 
mindfulness and mindfulness-based interventions are associated with increased activation 
in the stress-regulatory areas of the prefrontal cortex (Creswell, Way, Eisenberger, & 
Lieberman, 2007; Modinos, Ormel, & Aleman, 2010).  Additionally, in non-clinical 
samples, completion of an MBSR course has been linked to better immune function, 
increased left-sided anterior activation (associated with positive affect), lower levels of 
the inflammatory c-reactive protein, and decreased pro-inflammatory gene expression 
(Creswell et al., 2012; R. J. Davidson et al., 2003; Malarkey, Jarjoura, & Klatt, 2013).  In 
the cancer survivorship literature, yoga, an intervention with strong mindfulness 
components, has also been associated with decreased gene expression that contributes to 
chronic inflammation (Bower, Greendale, et al., 2014).  Furthermore, a recent trial of 
mindfulness meditation for breast cancer survivors found that at post-intervention, those 
in the intervention group had lower perceived stress, depressive symptoms, 
proinflammatory gene expression, and inflammatory signaling compared to a waitlist 
control group (Bower et al., 2015).  Sleep disturbance and fatigue have also been 
associated with higher levels of proinflammatory cytokines in cancer populations (Irwin, 
Olmstead, Ganz, & Haque, 2013; Raison & Miller, 2003).  However, specific 
mindfulness processes potentially underlying intervention effects on symptoms have yet 
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to be examined in relation to physiological changes in cancer survivors.  Research 
elucidating links between specific facets of mindfulness and common symptoms in 
cancer populations could inform future intervention designs.   
The Present Study 
The present study begins to address these gaps in the literature by analyzing data 
from a pilot MBSR trial targeting fatigue interference in cancer survivors.  Primary 
outcomes of the trial have been published (Johns et al., 2015).  At post-intervention, large 
effects were found for fatigue interference (d = -1.43), fatigue severity (d = -1.55), vigor 
(d = 1.29), and depression (d = -1.30) relative to a waitlist control group, and these 
effects were maintained at 1-month follow-up (ds = -1.34, -1.54, 1.73, and -1.71, 
respectively).  Medium effects were also found for disability status (d = -0.45), anxiety (d 
= -0.47), and sleep disturbance (d = -0.74) and were maintained or increased at 1-month 
follow-up (ds = -1.22, -0.98, and -1.00, respectively).  Changes in mindfulness, 
acceptance, and self-compassion were not reported in this paper. 
To further our understanding of the relationship between MBSR, psychological 
processes (i.e., mindfulness, acceptance, and self-compassion), and symptom outcomes in 
cancer survivors, the present study has two specific aims: 
Aim 1: To examine the impact of the MBSR intervention on facets of mindfulness 
(i.e., observing, describing, acting with awareness, nonjudging of inner experience, 
nonreactivity to inner experience), self-compassion, and acceptance in cancer survivors.  
Hypothesis 1: MBSR will lead to increased levels of the five facets of 
mindfulness (i.e., observing, describing, acting with awareness, nonjudging of inner 
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experience, nonreactivity to inner experience), self-compassion, and acceptance as 
compared to the WC condition. 
This hypothesis is based on theory linking MBSR to increases in mindfulness, 
self-compassion, and acceptance (Chawla & Ostafin, 2007; Kabat-Zinn, 1990; Neff, 
2003a; Shapiro et al., 2006).  In addition, these three psychological processes were 
specifically targeted in the current intervention through experiential exercises such as 
mindfulness meditation.  Although some evidence suggests that MBSR may impact 
mindfulness (Garland et al., 2013; Labelle et al., 2015; Shapiro et al., 2007), little is 
known regarding its impact on acceptance and self-compassion, especially in cancer 
populations.   
Aim 2: To examine the extent to which change in facets of mindfulness (i.e., 
observing, describing, acting with awareness, nonjudging of inner experience, 
nonreactivity to inner experience) predict change in fatigue interference, sleep 
disturbance, and distress in cancer survivors.  
Hypothesis 2: Positive change in the five facets of mindfulness will be linked to 
reduced fatigue interference, sleep disturbance, and distress in cancer survivors.   
Theorized cognitive and physiological pathways of mindfulness-based 
interventions  suggest that increased mindfulness may be linked to improvement in 
physical and psychological symptoms (Creswell & Lindsay, 2014; R. J. Davidson et al., 
2003; Nolen-Hoeksema et al., 2008; Shapiro et al., 2006).  Indeed, some intervention 
studies with general population samples have linked increases in mindfulness to reduced 
psychological symptoms (Carmody & Baer, 2008; Keng et al., 2012; Shapiro et al., 
2007).  Although limited, several intervention studies have reported links between 
24 
 
increased mindfulness and psychological symptom improvement in cancer patients 
(Bränström et al., 2010; Labelle et al., 2014; Nyklíček & Kuijpers, 2008).  However, 
associations between specific facets of mindfulness and physical and psychological 
symptom outcomes warrant further study. 
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CHAPTER 2. METHOD 
The present study is a secondary analysis of data from a Walther-funded 
randomized pilot study of MBSR for fatigued cancer survivors (Johns et al., 2015). The 
Indiana University Institutional Review Board and Indiana University Simon Cancer 
Center Scientific Review Committee approved study procedures.  This study complies 
with the Health Insurance Portability and Accountability Act (HIPAA). 
Participants 
Participants were recruited from clinics affiliated with the Indiana University 
Simon Cancer Center, Indiana University cancer research recruitment registries, or via 
self-referral upon receiving a study brochure at one of 13 support or treatment facilities in 
the Indianapolis area.  Eligible individuals were adult cancer survivors (18+ years of age) 
who reported clinically significant CRF for the past 8 weeks or longer.  CRF was 
considered clinically significant if the survivor had a score of 4 or higher on the 3-item 
Fatigue Symptom Inventory (FSI; Hann et al., 1998).  Individuals were excluded if they: 
(1) had received cancer treatment, including chemotherapy, biologic response modifiers, 
radiation therapy, surgery, or a bone marrow or stem cell transplant in the previous 3 
months; (2) were enrolled in hospice care; (3) had severe hearing impairment; (4) were 
experiencing severe depression (as defined by a score of ≥ 20 on the Patient Health 
Questionnaire-8 [PHQ-8]); (5) had previously taken a mindfulness meditation course; or 
(6) lacked English fluency. 
Of the 159 people who were assessed for eligibility, 67 (42%) did not meet the 
CRF clinical cutoff, 7 (4%) had severe depression, 2 (1%) had previous mindfulness 
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training, and 48 (30%) declined to participate.  Primary reasons for refusal were time 
constraints (71%), living too far away (10%), and lack of interest (6%).  The remaining 
35 individuals provided informed consent, completed the baseline assessment, and were 
randomized to either the MBSR class (n = 18) or the waitlist control (WC) condition (n = 
17).   
Participants were primarily diagnosed with breast cancer (86%), and most had 
early-stage disease (stages 0 to III) (94%).  The sample was, on average, White (80%), 
female (94%), 57.3 years of age (SD = 9.3), and college educated (71%).  Nearly half 
(49%) of participants were employed, 60% were married, and 60% reported having a 
comfortable income (versus just enough or not enough to make ends meet).  Additionally, 
all participants had completed active cancer treatment (chemotherapy and/or radiation 
therapy) at least 9 months prior to enrollment, with an average time between completion 
and study enrollment of 51.3 months (SD = 39.3 months).  About 23% of participants 
reported receiving mental health treatment in the past 6 months. 
Procedure 
Eligible participants attended one of two group enrollment sessions, which 
included the informed consent process, baseline assessment, and randomization to either 
MBSR or the WC group.  Randomization was completed in blocks of four by the 
principal investigator; thus, the research staff was blinded to the process.  Individuals 
randomized to the MBSR arm received a brief orientation to the intervention at the 
enrollment session.  Individuals in the WC condition were informed that they would be 
contacted in approximately 7 weeks to schedule the next study assessment. 
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The MBSR intervention was a series of 7 weekly classes, each 2 hours in length, 
and included psychoeducation related to CRF as well as home practice assignments.  The 
class was taught by a licensed physician with six years of experience teaching MBSR 
who remained blind to the home practice outcomes reported by participants at each 
weekly session.  The MBSR course was adapted for cancer survivors, but maintained 
fidelity to the standard MBSR program.  Adaptations for cancer survivors included 2-
hour classes rather than 2.5-hour classes, seven instead of eight classes, no extended day-
long retreat, the addition of psychoeducation related to CRF, and shorter (20-minute) 
home practice sessions.   
The first class session included an overview of the MBSR intervention and 
covered course logistics, including confidentiality among the group members.  The 
participants then practiced the skills of mindful eating, mindful breathing, and a body 
scan.  They were also introduced to the guided meditations and other exercises on the CD 
for assigned home practice each week.  In sessions 2 and 3, the participants practiced the 
body scan, were introduced to the practices of gentle hatha yoga and awareness of breath 
meditation, and learned about perceived stress and behavioral techniques for sleep 
hygiene.  In sessions 4 and 5, participants received further training in these skills, and an 
emphasis was placed on translating the skills to address stressors in everyday life.  In 
session 6, the participants deepened their training in mindfulness practices and discussed 
the full incorporation of the skills into their life, making them adaptable for various 
situations.  Finally, in session 7, the participants further practiced mindfulness exercises, 
reviewed and clarified course topics, and were provided with strategies to maintain their 
practice beyond the course.  Throughout the course, participants were encouraged to 
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practice daily mindfulness exercises and log the number of minutes and type of 
mindfulness practice on a diary card, which was submitted to a staff member at the 
following class session. 
Data were collected at 3 or 4 time points, depending on the randomization arm.  
The first 3 time points, baseline prior to randomization (T1), post-intervention (T2), and 
1-month follow-up (T3), were the same for both groups.  The WC group completed an 
additional assessment following completion of their respective MBSR course (T4).  All 
self-report measures were administered on paper-based forms.  Participants completed 
the baseline and post-intervention assessments in person, and the follow-up assessments 
were completed either on-site or mailed to the study team, depending on the participant’s 
preference.  Each participant received a $10 gift card to a local supermarket after 
completing the baseline assessment (T1), a $25 supermarket gift card after completing 
the post-intervention assessment (T2), and a $30 supermarket gift card after completing 
the 1-month follow-up assessment (T3).  Participants in the WC group received an 
additional $30 gift card for completing an assessment following their MBSR course (T4).   
Retention was excellent; all 35 participants completed assessments at T1, T2, and 
T3.  Only one participant did not complete the assessment at T4 (see Figure 1 for study 
flow chart). 
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Assessed for eligibility (n = 159) 
Excluded (n = 124) 
 Not meeting inclusion criteria (n = 76) 
Did not meet CRF clinical cutoff (n = 67) 
Severe depression (n = 7) 
Past mindfulness training (n = 2) 
 Declined to participate (n = 48) 
Completed Baseline (T1) assessment and 
randomized (n = 35) 
Allocated to MBSR (n = 18) 
 
 Completed MBSR (n = 18) 
Allocated to WC (n = 17) 
 
 
 Completed post-MBSR assessment 
(T2; n = 18) 
 
 
 Completed second baseline  
(T2; n = 17) 
 Completed third baseline 
(T3; n = 17) 
 
 Completed MBSR (n = 17) 
 Completed 1-month follow up  
(T3; n = 18) 
 
 Completed post-MBSR assessment 
(T4; n = 16) 
Figure 1: Intervention flow diagram. Adapted from Johns, S. A., Brown, L. F., Beck‐Coon, 
K., Monahan, P. O., Tong, Y., & Kroenke, K. (2015).  
CRF = cancer-related fatigue; MBSR = Mindfulness-based stress reduction; WC = waitlist 
control. 
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Measures 
Measures were administered at all time points to assess levels of mindfulness, 
acceptance, self-compassion, fatigue interference, sleep disturbance, and distress (see 
Appendix A). 
Psychological Processes 
Mindfulness 
Mindfulness was measured with the 39-item Five Factor Mindfulness 
Questionnaire (FFMQ; Baer, Smith, Hopkins, Krietemeyer, & Toney, 2006).  
Confirmatory factor analysis of five existing mindfulness questionnaires informed the 
development of the FFMQ.  It contains five subscales, each representing one facet of 
mindfulness: observing, describing, acting with awareness, nonjudging of inner 
experience, and nonreactivity to inner experience.  Participants rated how true each item 
was for them (e.g., “I perceive my feelings and emotions without having to react to 
them”) on a Likert-type scale from 1 (never or very rarely true) to 5 (very often or always 
true).  Cronbach’s alpha coefficients have ranged from .75 to .91 for the total instrument 
(Baer et al., 2006).  Good internal consistency was also found for each of the five facets: 
nonreactivity (α = 0.75), observing (α = 0.83), acting with awareness (α = 0.87), 
describing (α = 0.91), and nonjudging of inner experience (α = 0.87).  Construct validity 
has been established, as four of the facets (all except for acting with awareness) have 
been associated with meditation experience (Baer et al., 2008).  The FFMQ has been used 
with cancer populations, with generally good internal consistency (e.g., α= 0.92 for the 
total instrument) (Nakamura, Lipschitz, Kuhn, Kinney, & Donaldson, 2013). The current 
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sample also had good internal consistency for the total instrument (α= 0.94) and a similar 
pattern in the subscales: nonreactivity (α = 0.68), observing (α = 0.75), acting with 
awareness (α = 0.95), describing (α = 0.93), and nonjudging (α = 0.91). 
Acceptance 
Acceptance of experience was measured with the 10-item Acceptance and Action 
Questionnaire-II (AAQ-II; Bond et al., 2011).  Participants rated items such as “My 
painful experiences make it difficult for me to live a life that I would value” on a Likert-
type scale from 1 (never true) to 7 (always true).  Because the total scores reflect the 
opposite of acceptance (i.e., psychological inflexibility), the scores were reversed to 
capture acceptance and ease interpretation of results.  The scale has demonstrated 
adequate internal consistency, with a mean alpha coefficient of .84 (Bond et al., 2011).  
Evidence of construct validity includes relationships between greater psychological 
inflexibility on the AAQ-II and higher levels of depressive symptoms, anxiety, stress, and 
other psychopathology (Bond et al., 2011).  Recent studies with cancer patients have 
found the internal consistency of the AAQ-II to be acceptable (αs ranging from 0.78 to 
0.87 during the course of the study) (Feros et al., 2013; Labelle et al., 2015).  Internal 
consistency for the AAQ-II in the current sample was good (α = 0.86). 
Self-compassion 
Attitudes associated with self-compassion were assessed with the 12-item Self-
Compassion Scale-Short Form (SCS-SF; Neff, 2003).  The measure contains 3 positive 
subscales (self-kindness, common humanity, and mindfulness) and 3 reverse-scored 
negative subscales (isolation, self-judgment, and over-identification), which are typically 
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summed to create a total composite score for overall level of self-compassion.  
Participants rated each item (e.g., “When I’m going through a very hard time, I give 
myself the caring and tenderness I need”) on a Likert-type scale ranging from 1 (almost 
never) to 5 (almost always).  The SCS-SF has shown good internal consistency with 
Cronbach’s alphas of .86 or higher and is highly correlated with the long-form of the 
scale (r ≥ 0.97 in all samples) (Raes, Pommier, Neff, & Van Gucht, 2011).  The SCS-SF 
also has demonstrated good discriminant validity, as it is not related to social desirability 
(Neff, 2003b).  In addition, the SCS-SF is negatively correlated with self-criticism and 
positively correlated with social connectedness, providing evidence of construct validity 
(Neff, 2003b).  Recent studies using the SCS with cancer populations found high internal 
consistency for both the full length scale (αs = 0.96 and 0.92) (Nakamura et al., 2013; 
Przezdziecki et al., 2013) and the short form (α = 0.91) (Sherman, Woon, French, & 
Elder, 2016).  In the current sample, internal consistency of the SCS-SF was high (α = 
0.90). 
Symptom Outcomes 
Fatigue interference 
Fatigue interference was assessed using the Fatigue Symptom Inventory (FSI; 
Hann et al., 1998) 7-item interference subscale (items 5-11).  Each item is rated on an 11-
point Likert-type scale from 0 (no interference) to 10 (extreme interference).  A sample 
item for fatigue interference is “Rate how much, in the past week, fatigue interfered with 
your ability to concentrate.”  The FSI has been validated in samples of men and women 
with different types of cancer (Hann, Denniston, & Baker, 2000).   Construct validity was 
evidenced by negative correlations with life satisfaction and positive correlations with 
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depressive symptoms.  Additionally, patients undergoing cancer treatment showed higher 
FSI scores than those who were less than one year post-treatment.  Convergent validity 
also was evidenced by strong positive correlations of the FSI with an existing measure of 
fatigue.  The overall internal consistency for the interference subscale was excellent (α = 
0.94).  In the current sample, internal consistency for the interference subscale was also 
excellent (α = 0.95). 
Sleep Disturbance 
Sleep disturbance was assessed using the 7-item Insomnia Severity Index (ISI; 
Morin, 1993).  The measure assesses perceived severity of insomnia as well as the impact 
of sleep difficulties on daily functioning over the course of the previous two weeks.  The 
ISI employs a 5-point Likert-type scale from 0 (none) to 4 (very) with varying anchors 
(e.g., interference, satisfaction).  A sample item asks for level of “difficulty falling 
asleep.”  Construct validity for cancer patients was evidenced by positive correlations 
with other established measures of sleep and negative correlations with quality-of-life 
(M. H. Savard, Savard, Simard, & Ivers, 2005).  Cronbach’s alpha for the ISI in a sample 
of 1,634 cancer patients was .90 (M. H. Savard et al., 2005).  The current sample also had 
high internal consistency on the ISI (α = 0.90). 
Distress 
Distress levels were calculated by summing the z-scores of a depressive 
symptoms measure and an anxiety symptoms measure.  Levels of depressive symptoms 
were measured with the 8-item Patient Health Questionnaire-8 (PHQ-8; Kroenke, 
Spitzer, & Williams, 2001).  The PHQ-8 omits the suicidality item in the PHQ-9 because 
34 
 
the endorsement of the item is low, and the present trial did not have a core focus on 
depression.  Furthermore, the PHQ-9 and PHQ-8 do not significantly differ in sensitivity, 
specificity, and positive predictive value in diagnosing probable depression in the general 
population (Kroenke & Spitzer, 2002).  Participants rated each of the 8 items, such as 
how often they were bothered by “feeling down, depressed, or hopeless” in the past two 
weeks, on a Likert-type scale.  Response options were 0 = not at all, 1 = several days, 2 = 
more than half the days, and 3 = nearly every day.  Cronbach’s alpha for the PHQ-9 in 
prior research was 0.89 (Kroenke et al., 2001).  While this instrument has not been 
normed specifically for cancer populations, it has undergone rigorous validity testing in 
many other large samples of medical populations (Arroll et al., 2010; Kroenke et al., 
2009; Martin, Rief, Klaiberg, & Braehler, 2006).  Construct validity was determined 
through linking higher PHQ-9 scores to lower functional status, more disability days, 
greater symptom-related difficulty, and increased used of health services (i.e., clinic 
visits) (Kroenke et al., 2001).  The PHQ-8 has also been administered to cancer 
populations with evidence of good internal consistency (e.g., α = .87) (Gonzalez et al., 
2014; Mosher et al., 2016; Reyes-Gibby, Anderson, Morrow, Shete, & Hassan, 2012). In 
the current sample, internal consistency for the PHQ-8 was adequate (α = 0.83). 
Level of anxiety was assessed using the 7-item Patient Health Questionnaire 
Generalized Anxiety Disorder Scale (GAD-7) (Kroenke, Spitzer, Williams, Monahan, & 
Lowe, 2007).  This scale is useful for detecting symptoms of generalized anxiety 
disorder, among other related disorders, such as panic disorder, social anxiety disorder, 
and posttraumatic stress disorder.  For each item, respondents rated how often in the past 
two weeks they were bothered by certain emotions, such as “not being able to stop or 
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control worrying” on a 4-point Likert-type scale.  Response options were 0 = not at all, 1 
= several days, 2 = more than half the days, and 3 = nearly every day.  The GAD-7 
demonstrated good construct validity in general population samples through correlations 
with other related constructs, such as depression, life satisfaction, and self-esteem (Löwe 
et al., 2008), and has been used in studies with cancer patients (L. F. Brown, Kroenke, 
Theobald, Wu, & Tu, 2010; Kroenke, Theobald, Wu, Loza, et al., 2010; Kroenke, 
Theobald, Wu, Norton, et al., 2010). Cronbach’s alpha for the GAD-7 in the general 
population is .89 (Löwe et al., 2008). In the current sample, Cronbach’s alpha for the 
GAD-7 was 0.85. 
Demographics 
Participants reported their age, gender, race, education, marital status, income, 
work status, and history of mental health treatment.  This treatment was assessed via two 
questions regarding whether the participant had received mental health care within the 
last 6 months (current treatment) or the past 5 years (past treatment).  Types of mental 
health treatment were not collected. 
Medical Information 
Diagnosis date and cancer treatment history, including treatment types and dates, 
were collected via medical record review following informed consent. 
Data Analysis 
Data analysis was completed using SPSS version 23.0 (IBM Corp., Armonk, NY, 
USA).  There were minimal missing data.  Series mean imputation was employed to 
handle the three missing values to optimize use of all existing data.  Prior to completing 
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the analyses, all continuous data were examined for normality violations.  These were 
determined by cutoffs of the absolute values of 3 and 10 for skewness and kurtosis, 
respectively (Kline, 2011).  There were no normality violations and, therefore, no 
variable transformations were performed.  
To begin, baseline comparisons (t-tests and Chi-square analyses or Fisher’s exact 
tests) of demographic and medical characteristics and study variables between the MBSR 
and WC groups were conducted.  To examine the impact of the MBSR intervention on 
five facets of mindfulness (i.e., observing, describing, acting with awareness, nonjudging 
of inner experience, nonreactivity to inner experience), self-compassion, and acceptance 
in cancer survivors (study aim #1), I employed a linear mixed-modeling approach in 
SPSS.  An intent-to-treat framework was selected to make use of all available data; 
however, this was not employed due to lack of participant drop-out.  Each model 
included the main effects of time (T1, T2, and T3) and study group (MBSR or WC) and 
the time × group interaction.  Both time and study group were treated as categorical 
variables in these models, focusing the analyses on average differences between groups 
and across time.  A significant treatment effect is evidenced either by a significant study 
group main effect or a significant time × group interaction. 
To examine the extent to which change in mindfulness facets (i.e., observing, 
describing, acting with awareness, nonjudging of inner experience, and nonreactivity to 
inner experience),  predicted change in symptom outcomes (fatigue interference, sleep 
disturbance, and distress) (study aim #2),  I first merged data collected from the WC 
group at T3 with data collected from the intervention group at T1; thus, the new variables 
reflected all data collected just prior to starting the MBSR courses.  Data collected from 
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the WC group at T4 were merged with data collected from the intervention group at T2 to 
reflect post-treatment data collected from both groups.  Following data reorganization, I 
utilized multiple linear regression models to determine the relationship between change 
in each of the five facets of mindfulness and change in each of the three symptom 
outcomes.  Thus, I examined a total of 15 models.  To evaluate intra-individual level 
change, I calculated residualized change scores for each facet of mindfulness.  This 
method was selected over simple change scores because the latter is associated with 
baseline scores, while residualized change scores are measures of relative change rather 
than absolute change (Hauser-Cram & Krauss, 1991).  In accordance with Cronbach and 
Furby (1970),  I first computed a raw change score by subtracting the baseline value of 
each facet of mindfulness from the post-treatment value of each facet.  Second, a linear 
regression model was used to calculate predicted post-treatment values of each facet of 
mindfulness from the baseline values.  Next, a predicted change score was calculated 
from the difference of these two values.  The predicted change score was then subtracted 
from the actual change score to calculate the residualized change score.  Each of the 15 
models had the pre-treatment symptom level in step 1, the residualized change score for 
the mindfulness facet in step 2, and the post-treatment symptom level as the dependent 
variable. 
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CHAPTER 3. RESULTS 
Preliminary Analyses 
Participant Characteristics 
Table 1 shows participant characteristics for the MBSR and WC groups.  
Participants were primarily diagnosed with breast cancer (83% MBSR, 88% WC).  The 
sample was, on average, White (83% MBSR, 76% WC), female (94% in both MBSR and 
WC), middle-aged (58.8 years MBSR, 55.7 years WC), and college educated (61% 
MBSR, 76% WC).  Nearly half (50% MBSR, 47% WC) of participants were employed, 
and the majority (61% MBSR, 59% WC) were married.  Fifty percent of the MBSR 
group and 71% of the WC group reported having a comfortable income (versus just 
enough or not enough to make ends meet).  About 23% (6% MBSR, 41% WC) of 
participants reported receiving mental health treatment in the past 6 months.   
Chi-square analyses were conducted to examine participant characteristics by 
group assignment, unless cells had expected counts of less than 5, in which case Fisher’s 
exact test was used.  There were no significant demographic or medical differences 
between the groups, except for the higher rate of mental health treatment at baseline for 
WC participants compared to MBSR participants (see Table 1).  
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Table 1: Comparison of Baseline Characteristics by Group Assignment 
 
 
MBSR  
(n = 18) 
 
WC  
(n = 17) 
   
Baseline Characteristics 
Number of 
Participants 
(%) 
Number of 
Participants 
(%) χ2/ t df P 
Age, mean (SD) 58.8 (9.3) 55.7 (9.3) -0.99 33 0.84 
White racea 15 (83) 13 (76) -- -- 0.34 
Female gendera 17 (94) 16 (94) -- -- 1.00 
College graduate 11 (61) 13 (76) 0.96 1 0.33 
Marrieda 11 (61) 9 (59) 0.24 1 0.63 
Employed (full or part-
time) 
9 (50) 8 (47) 0.03 1 0.86 
Comfortable income 9 (50) 12 (71) 1.54 1 0.21 
Recent mental health 
treatmenta 
1 (6) 7 (41) -- -- 0.02* 
Cancer type      
Breasta 15 (83) 15 (88) -- -- 1.00 
Esophageala 2 (11) 0 (0) -- -- 0.49 
Leukemiaa 1 (6) 0 (0) -- -- 1.00 
Lymphomaa 1 (6) 2 (12) -- -- 0.60 
Thyroida 1 (6) 0 (0) -- -- 1.00 
Melanomaa 1 (6) 0 (0) -- -- 1.00 
Treatment type      
Chemotherapy 11 (61) 12 (71) 0.35 1 0.56 
Radiation therapy 10 (56) 12 (71) 0.85 1 0.36 
Chemotherapy + 
radiation therapy 
7 (39) 8 (47) 0.24 1 0.63 
Endocrine therapy 12 (67) 8 (47) 1.37 1 0.24 
Surgerya 14 (78) 15 (88) -- -- 0.66 
Bone marrow / stem cell 
transplanta 
1 (6) 0 (0) -- -- 1.00 
Note.  MBSR = Mindfulness-based stress reduction; WC = waitlist control; SD = 
standard deviation.   
aFisher’s Exact Test was used due to small cell sizes.   
*p < 0.05. 
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Study Variables 
Independent samples t-tests were used to examine whether the main study 
variables differed between the MBSR and WC groups at baseline (see Table 2).  Levels 
of acceptance, observing, and nonreactivity were significantly lower for WC participants 
compared to MBSR participants.  All other study variables did not differ between groups. 
 
Table 2: Comparison of Main Study Variables at Baseline by Group Assignment 
 
MBSR  
(n = 18) 
WC 
(n = 17)    
Variable at Baseline Mean (SD) Mean (SD) t df P 
Mindfulness facet      
Observing 28.11 (5.29) 24.35 (5.27) -2.10 33 0.04* 
Describing 29.94 (5.87) 27.06 (7.91) -1.23 33 0.23 
Acting with Awareness 26.78 (6.32) 22.00 (8.66) -1.87 33 0.07 
Nonjudging 31.61 (6.09) 28.35 (7.75) -1.39 33 0.18 
Nonreactivity 23.78 (3.57) 20.65  (3.72) -2.54 33 0.02* 
Acceptancea 53.50 (8.33) 46.29 (11.94) -2.08 28.42 0.05* 
Self-compassiona 42.67 (6.52) 36.73 (11.87) -1.82 24.53 0.08 
Fatigue interference 4.34 (2.19) 4.46 (2.02) 0.16 33 0.88 
Sleep disturbance 11.17 (6.67) 13.29 (7.05) 0.92 33 0.37 
Distress -.32 (1.83) .34 (1.84) 1.07 33 0.29 
Note. MBSR = Mindfulness-based stress reduction; WC = waitlist control; SD = standard 
deviation.   
Distress scores are standardized. 
aLevene’s test determined variances were unequal across groups. Therefore, t-tests were 
conducted with no assumption of equal variance. 
*p < 0.05. 
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Normality Assumptions 
Normality of the study variables was assessed by examining skewness and 
kurtosis.  All variables were within Kline’s (2011) recommended normality guidelines 
(i.e., skewness indices were < |3.0| and kurtosis indices were < |10.0|) (see Table 3). 
There were three missing responses across all study questions (i.e., three participants did 
not answer one question each).  Missing responses were addressed using the series mean 
imputation approach, in which the missing value was replaced by the mean value of the 
variable. 
 
Table 3: Skewness and Kurtosis of Study Variables 
 
  
 
Skewness Kurtosis 
Variable 
Baseline 
(T1) 
Post-
intervention 
(T2) 
1-Month 
Post-
Intervention 
(T3) 
Baseline 
(T1) 
Post-
intervention 
(T2) 
1-Month 
Post-
Intervention 
(T3) 
Mindfulness        
Observing -.39 -.33 -.55 .41 -.57 .73 
Describing -.98 -.88 -1.09 .55 .64 1.71 
Acting with 
Awareness 
-.28 -.30 -.32 -.74 -.53 -.55 
Nonjuding -.84 -.84 -1.04 .47 .61 .65 
Nonreactivity .85 -.37 -.54 1.43 .29 1.57 
Acceptance -.81 -.92 -.89 -.08 .62 .24 
Self-compassion -.51 -.60 -.69 -.20 -.32 -.17 
Fatigue 
Interference 
-.40 .39 .72 .03 -.19 -.48 
Sleep Disturbance .39 .60 .66 -.48 -.26 -.51 
Distress .38 1.16 .73 -.49 1.88 -.66 
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Study Hypothesis 1 
Seven linear mixed models were conducted to examine the impact of MBSR on 
five facets of mindfulness, acceptance, and self-compassion.  The first study hypothesis 
was that MBSR would lead to increased levels of the five facets of mindfulness (i.e., 
observing, describing, acting with awareness, nonjudging of inner experience, 
nonreactivity to inner experience), self-compassion, and acceptance as compared to the 
WC condition.  
This hypothesis was supported.  Mixed model analyses revealed significant main 
effects of group in favor of MBSR for all facets of mindfulness (observing, describing, 
acting with awareness, nonjudging, and nonreactivity), acceptance, and self-compassion 
(see Figures 2-8 and Table 4).   
Analyses also showed significant group × time effects for observe (F(2,66) = 
4.86, p = 0.01), acting with awareness (F(2,66) = 3.54, p = 0.04), nonjudging (F(2,66) = 
4.27, p = 0.02), and self-compassion (F(2,66) = 6.55, p < 0.01) (see Table 4).  The 
interaction means found in Figures 2, 4, 5, and 6 show steady increases in each of these 
psychological processes for the MBSR group, whereas the mean scores for the WC group 
remained relatively stable or slightly declined over time.  
 
  
Table 4: Intent-To-Treat Results of Mixed Models Predicting Effects of MBSR on Psychological Processes 
 MBSR  WC    
 
 
 
 
Baseline (T1) 
 
Post-
Intervention 
(T2) 
1-Month 
Post-
Intervention 
(T3) 
  
 
 
Baseline (T1) 
 
Post-
Intervention 
(T2) 
1-Month 
Post-
Intervention 
(T3) 
   
Outcome Fixed 
Effect 
Mean (SD) Mean (SD) Mean (SD) 
 
Mean (SD) Mean (SD) Mean (SD) df F P 
Mindfulness: 
Observing 
28.10 (5.29) 30.56 (5.52) 31.78 (4.62)  24.35 (5.28) 23.00 (6.57) 23.88 (5.54)    
Group        33 15.05 0.00** 
Time        66 2.43 0.10 
Group × Time        66 4.86 0.01** 
Mindfulness: 
Describing 
29.94 (5.87) 32.00 (4.93) 31.78 (5.00)  27.06 (7.91) 26.35 (9.13) 26.77 (7.63)    
Group        33 4.26 0.05* 
Time        66 0.74 0.48 
Group × Time        66 2.20 0.12 
Mindfulness: Acting 
with Awareness 
26.78 (6.32) 27.78 (4.67) 29.33 (5.29) 
 
22.00 (8.66) 23.00 (8.95) 21.00 (8.95)    
Group        33 6.69 0.01** 
Time        66 0.93 0.40 
Group × Time        66 3.54 0.04* 
Mindfulness: 
Nonjudging 
31.61 (6.09) 32.89 (4.27) 34.11 (4.96) 
 
28.35 (7.75) 27.12 (8.51) 25.94 (9.52)    
Group        33 6.91 0.01** 
Time        66 .001 0.10 
Group × Time        66 4.27 0.02* 
 
 
 
4
3
 
  
Table 4 continued 
Mindfulness: 
Nonreactivity 
23.78 (3.57) 24.17 (3.60) 25.83 (3.63) 
 
20.64 (3.72) 21.00 (5.94) 21.06 (4.45)    
Group        33 9.46 0.00** 
Time        66 1.78 0.17 
Group × Time        66 0.98 0.38 
Acceptance 53.50 (8.33) 55.67 (7.78) 55.5 (9.94)  46.29 (11.95) 47.94 (12.67) 45.82 (13.92)    
Group        33 5.64 0.02* 
Time        66 1.41 0.25 
Group × Time        66 0.65 0.53 
Self-Compassion 42.67 (6.52) 44.89 (7.61) 47.28 (7.00)  36.73 (11.87) 37.37 (12.02) 35.35 (13.10)    
Group        33 6.88 0.01** 
Time        66 2.13 0.13 
Group × Time        66 6.55 0.00** 
Note. MBSR = Mindfulness-based stress reduction; WC = waitlist control; df = degrees of freedom; SD = standard deviation.  
*p < 0.05. **p < 0.01. 
 
4
4
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Figure 2: Plotted mean mindfulness: observing score (FFMQ subscale) by study time 
point.  FFMQ = Five Facet Mindfulness Questionnaire; MBSR = Mindfulness-based 
stress reduction; WC = waitlist control. 
 
 
Figure 3:  Plotted mean mindfulness: describing score (FFMQ subscale) by study time 
point.  FFMQ = Five Facet Mindfulness Questionnaire; MBSR = Mindfulness-based 
stress reduction; WC = waitlist control. 
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Figure 4: Plotted mean mindfulness: acting with awareness score (FFMQ subscale) by 
study time point.  FFMQ = Five Facet Mindfulness Questionnaire; MBSR = 
Mindfulness-based stress reduction; WC = waitlist control. 
 
Figure 5: Plotted mean mindfulness: nonjudging score (FFMQ subscale) by study time 
point.  FFMQ = Five Facet Mindfulness Questionnaire; MBSR = Mindfulness-based 
stress reduction; WC = waitlist control. 
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Figure 6: Plotted mean mindfulness: nonreactivity score (FFMQ subscale) by study time 
point.  FFMQ = Five Facet Mindfulness Questionnaire; MBSR = Mindfulness-based 
stress reduction; WC = waitlist control. 
 
Figure 7: Plotted mean acceptance score (AAQ-II) by study time point.  AAQ-II = 
Acceptance and Action Questionnaire-II; MBSR = Mindfulness-based stress reduction; 
WC = waitlist control. 
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Figure 8: Plotted mean self-compassion score (SCS-SF) by study time point.  SCS-SF = 
Self-Compassion Scale-Short Form; MBSR = Mindfulness-based stress reduction; WC = 
waitlist control. 
Study Hypothesis 2 
The second study hypothesis was that positive change in the five facets of 
mindfulness would be linked to reduced fatigue interference, sleep disturbance, and 
distress.  This hypothesis was tested using 15 multiple linear regression models, with 
residualized change in each of the five facets of mindfulness examined as predictors of 
change in each of the three symptom outcomes.   
Results partially supported my hypothesis.  As shown in Table 5, acting with 
awareness showed a modest negative association with fatigue interference (β = -.24); 
however, this result fell short of statistical significance (p = .07).  Changes in other 
aspects of mindfulness were not related to change in fatigue interference.  Results also 
demonstrated that increases in acting with awareness and nonjudging were significantly 
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associated with lower levels of sleep disturbance post-intervention (acting with 
awareness: β = -.31, p = .02; nonjudging: β = -.39, p < .01) (see Table 6).  Change in 
other facets of mindfulness did not predict change in sleep disturbance.  The third set of 
analyses found that increases in observing, acting with awareness, nonjudging, and 
nonreactivity were significantly associated with decreases in distress post-intervention 
(observing: β = -.30, p = .02; acting with awareness: β = -.36, p < .01; nonjudging: β = -
.27, p = .03; nonreactivity: β = -.26, p = .04), but describing was unrelated to change in 
distress (see Table 7).   
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Table 5: Regression of Post-intervention Fatigue Interference on Residualized 
Change in Mindfulness Facet Scores, Controlling for Pre-intervention Fatigue 
Interference 
 
Predictors 
Standardized 
β 
Unstandardized 
β 
 
SE 
 
R2 
 
ΔF 
 
P 
Step 1       
Pre-intervention fatigue 
interference 
.64 .50 .53 .41 23.00 .00** 
Step 2       
Residualized change in 
mindfulness: Observing  
-.02 -.01 .06 .41 .03 .87 
       
Step 1       
Pre-intervention fatigue 
interference 
.64 .50 .10 .41 22.99 .00** 
Step 2       
Residualized change in 
mindfulness: Describing  
.04 .02 .06 .41 .10 .76 
       
Step 1       
Pre-intervention fatigue 
interference 
.64 .50 .10 .41 22.99 .00** 
Step 2       
Residualized change in 
mindfulness: Acting with 
Awareness  
-.24 -.08 .05 .47 3.45 .07 
       
Step 1       
Pre-intervention fatigue 
interference 
.64 .50 .10 .41 22.99 .00** 
Step 2       
Residualized change in  
mindfulness: Nonjudging 
.02 .01 .05 .41 .01 .91 
       
Step 1       
Pre-intervention fatigue 
interference 
.64 .50 .10 .41 22.99 .00** 
Step 2       
Residualized change in 
mindfulness: Nonreactivity  
-.08 -.04 .08 .42 .31 .58 
Note. SE = standard error.  *p < 0.05. **p < 0.01. 
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Table 6: Regression of Post-intervention Sleep Disturbance on Residualized 
Change in Mindfulness Facet Scores, Controlling for Pre-intervention Sleep Disturbance 
 
Predictors 
Standardized 
β 
Unstandardized 
β 
 
SE 
 
R2 
 
ΔF 
 
P 
Step 1       
Pre-intervention sleep 
disturbance 
.61 .64 .15 .37 19.10 .00** 
Step 2       
Residualized change in 
mindfulness: Observing 
-.14 -.23 .25 .38 .85 .36 
       
Step 1       
Pre-intervention sleep 
disturbance 
.61 .64 .15 .37 19.10 .00** 
Step 2       
Residualized change in 
mindfulness: Describing 
-.04 -.06 .25 .37 .06 .80 
       
Step 1       
Pre-intervention sleep 
disturbance 
.61 .64 .15 .37 19.10 .00** 
Step 2       
Residualized change in 
mindfulness: Acting with 
Awareness  
-.31 -.43 .18 .46 5.81 .02* 
       
Step 1       
Pre-intervention sleep 
disturbance 
.61 .64 .15 .37 19.10 .00** 
Step 2       
Residualized change in 
mindfulness: Nonjudging  
-.39 -.55 .17 .52 10.30 .00** 
       
Step 1       
Pre-intervention sleep 
disturbance 
.61 .64 .15 .37 19.10 .00** 
Step 2       
Residualized change in 
mindfulness: Nonreactivity 
-.21 -.46 .30 .41 2.34 .14 
Note. SE = standard error.  *p < 0.05. **p < 0.01. 
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Table 7: Regression of Post-intervention Distress on Residualized Change in 
Mindfulness Facet Scores, Controlling for Pre-intervention Distress 
Predictors 
Standardized 
β 
Unstandardized 
β 
SE R2 ΔF P 
Step 1       
Pre-intervention distress .69 .55 .10 .47 29.63 .00** 
Step 2       
Residualized change in 
mindfulness: Observing 
-.30 -.11 .04 .56 6.26 .02* 
       
Step 1       
Pre-intervention distress .69 .55 .10 .47 29.63 .00** 
Step 2       
Residualized change in 
mindfulness: Describing 
-.14 -.05 .05 .49 1.06 .31 
       
Step 1       
Pre-intervention distress .69 .55 .10 .47 29.63 .00** 
Step 2       
Residualized change in 
mindfulness: Acting with 
Awareness  
-.36 -.11 .03 .60 10.31 .00** 
       
Step 1       
Pre-intervention distress .69 .55 .10 .47 29.63 .00** 
Step 2       
Residualized change in 
mindfulness: Nonjudging  
-.27 -.08 .04 .54 4.99 .03* 
       
Step 1       
Pre-intervention distress .69 .55 .10 .47 29.63 .00** 
Step 2       
Residualized change in 
mindfulness: Nonreactivity 
-.26 -.12 .06 .54 4.69 .04* 
Note. SE = standard error.  *p < 0.05. **p < 0.01. 
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CHAPTER 4. DISCUSSION 
This present study aimed to expand our understanding of MBSR’s effects on 
mindfulness, acceptance, and self-compassion and the specific facets of mindfulness that 
may be related to symptom reduction in cancer survivors.  Previous studies with cancer 
and non-cancer samples have found a positive effect of MBSR on global mindfulness (K. 
W. Brown & Ryan, 2003; Gu et al., 2015), but the impact of MBSR and other 
mindfulness-based interventions on specific facets of mindfulness and other theory-
driven psychological processes (e.g., acceptance) is largely unknown.  The present study 
also provides initial information on the degree to which changes in individual facets of 
mindfulness following MBSR predict changes in common cancer-related symptoms.  
This information will inform the design of future MBSR interventions for symptomatic 
cancer survivors. 
Consistent with my hypothesis, MBSR resulted in higher levels of observing, 
acting with awareness, nonjudging, and self-compassion as compared to the WC 
condition.  Specifically, the MBSR group showed steady increases in each of these 
psychological processes over time, whereas the means for the WC group remained 
relatively stable or slightly declined over time.  This result converges with prior research, 
which has shown that mindfulness-based interventions for cancer populations lead to 
increases in global mindfulness (Boyle et al., 2017; Foley, Baillie, Huxter, Price, & 
Sinclair, 2010; Garland et al., 2013; Labelle et al., 2010) as well as specific facets of 
mindfulness (Bränström et al., 2010; Labelle et al., 2015, 2014).  Because theory suggests 
that MBSR participants become less avoidant and more flexible in their approach towards 
their illness or disorder (Kabat-Zinn, 1990), the increases in psychological processes that 
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would facilitate psychological flexibility were expected.  As participants develop 
mindfulness skills through intervention exercises, they are better able to observe internal 
experiences, such as fatigue, in a non-judgmental fashion and engage in valued activities 
despite their symptom burden.  For example, through practicing the awareness of breath 
sitting meditation, participants learn to acknowledge symptoms without trying to change 
them and return their attention to their breath.  Similarly, exercises such as the guided 
lovingkindness meditation promote a sense of kindness and patience for oneself, thus 
improving self-compassion as this practice permeates into daily life (e.g., during times of 
high symptom burden).  Together, the MBSR exercises and didactics facilitate the 
development of key psychological processes that can potentially reduce suffering related 
to symptom burden.  
In contrast, both the MBSR and WC groups showed stability in describing, 
nonreactivity, and acceptance across study time points, with the MBSR group having 
higher levels of these psychological processes.  The lack of change in describing may be 
explained by its relatively high scores at baseline (29.94 for the MBSR group and 27.04 
for the WC group), creating a ceiling effect.  Thus, most participants endorsed the ability 
to describe their internal experiences throughout the study.  Conversely, ceiling effects do 
not explain the lack of change in nonreactivity and acceptance, as there was ample room 
for positive change in both variables (approximately 12-14 points for nonreactivity and 
17-24 points for acceptance).   
MBSR’s standardized curriculum was designed to reinforce the development of 
all facets of mindfulness, including nonreactivity and acceptance; thus, the lack of change 
in these two variables does not appear to be explained by the intervention components.  
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For example, the body scan is one of the core activities in MBSR and targets all 
mindfulness facets.  Participants begin by noticing sensations in different parts of the 
body (observing) and then sharing with the group what they noticed (describing).  For 
example, a participant might have noticed neuropathic pain and allowed herself to 
recognize that this is a persistent side effect of treatment and feel sad in that moment 
(acceptance).  If the participant was able to practice mindfulness, this sadness would not 
be judged as weakness (nonjudging), and thoughts and feelings would be noticed without 
getting caught up in them (nonreactivity).  In addition, the participant would be able to 
fully engage in the body scan exercise without attempts to avoid this experience (acting 
with awareness).  Thus, as illustrated by this exercise, the nature of the intervention is 
unlikely to explain the lack of change in nonreactivity and acceptance. 
The measurement of nonreactivity and acceptance also should be considered 
when interpreting the stable findings.  When examining the nonreactivity subscale of the 
FFMQ, the majority of the items (five out of seven) require the endorsement of negative 
experiences (e.g., “When I have distressing thoughts or images, I am able to just notice 
them without reacting”).  In addition, the items refer to what is “generally true” for the 
participant without specifying a time frame.  Thus, participants were recalling their 
responses to challenges at varying time frames, which may have rendered the measure 
insensitive to intervention effects.  The AAQ-II measure of acceptance also does not 
reference a time frame.  Developing measures of acceptance and nonreactivity that assess 
state psychological processes rather than traits is an important direction for future 
research.  
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Next, I examined whether positive change in the five facets of mindfulness (i.e., 
observing, describing, acting with awareness, nonjudging of inner experience, 
nonreactivity to inner experience) would predict change in fatigue interference, sleep 
disturbance, and distress in cancer survivors.  The observing facet was linked to 
decreased distress, but not fatigue interference or sleep disturbance.  This particular facet 
has performed poorly in prior research (Baer et al., 2006; Desrosiers, Klemanski, & 
Nolen-Hoeksema, 2013).  Specifically, the five-factor model of mindfulness that included 
the observing facet had poor fit for a meditation-naïve sample (Baer et al., 2006).  The 
current group of participants did not have a history of meditation experience at baseline; 
thus the observing subscale may not have been a psychometrically sound measure for this 
group.  Additionally, in previous research, the observing facet has been related to both 
adaptive and maladaptive psychological characteristics (Baer et al., 2006; Desrosiers et 
al., 2013).  For example, one cross-sectional study of  undergraduate students found that 
observing was positively associated with openness, emotional intelligence, and self-
compassion, but was also positively associated with dissociation, absent-mindedness, 
psychological symptoms, and thought suppression (Baer et al., 2006).  Another cross-
sectional study of people seeking mental health treatment found that observing was 
positively correlated with anxious arousal (Desrosiers et al., 2013), which has been 
associated with increased interoceptive awareness (Dunn et al., 2010).  Thus, one 
possible explanation for negative findings is that higher levels of observing without the 
practice of other facets of mindfulness (e.g., nonjudging, nonreactivity) may lead to 
heightened awareness of negative internal experiences that is followed by attempts to 
control these experiences (e.g., thought suppression).  Indeed, in prior research, higher 
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levels of observing were associated with lower levels of nonjudging in samples without 
meditating experience (Baer et al., 2006), whereas this association was positive for those 
with this experience (Baer et al., 2008).  These findings suggest that higher reported 
levels of observing correspond with less judgment of one’s experiences following 
mindfulness training.  In the present study, participants engaged in exercises targeting all 
facets of mindfulness; thus, it is not surprising that positive change in observing was 
associated with decreased distress.  Future research may examine interaction effects 
between observing and other facets of mindfulness to elucidate its contribution to the 
experience of physical and psychological symptoms.   
Contrary to my hypothesis, the describing facet of mindfulness did not predict 
changes in distress, sleep disturbance, or fatigue.  Although labeling internal experiences 
with words is a core feature of various exercises within the MBSR framework, this ability 
on its own may not lead to significant reductions in symptoms.  For example, higher 
levels of describing may bring more awareness to the unpleasant sensation or experience, 
but if one continues to judge and react to that experience, the negative experience may 
become more salient for the individual.  In future research it may be important to 
examine whether other facets of mindfulness (e.g., nonjudging) moderate the association 
between describing and symptom outcomes.  In addition, the measurement of describing 
warrants attention in future studies.  To date, research utilizing both the full-length and 
short-form versions of the FFMQ has shown average scores for describing to be 
consistently high (Bohlmeijer, ten Klooster, Fledderus, Veehof, & Baer, 2011; Bränström 
et al., 2010; Carmody & Baer, 2008), and average scores for describing were relatively 
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high at baseline in the current study.  Therefore, there may have been little room for 
positive change in this facet of mindfulness. 
A key finding of this study is that increases in acting with awareness predicted 
decreases in distress and sleep disturbance, as well as a modest decrease in fatigue 
interference that fell short of statistical significance (p = .07).  The negative relationship 
between acting with awareness and distress is consistent with findings from previous 
cross-sectional studies with samples who had varying levels of meditation experience 
(Baer et al., 2008, 2006; Cash & Whittingham, 2010).  This result is also consistent with 
findings from a MBSR intervention study with cancer patients, where acting with 
awareness accounted for the decrease in specific symptoms of stress (peripheral 
manifestations, muscle tension, and emotional irritability) (Garland et al., 2013).  The 
relationship between acting with awareness and distress may be a function of increased 
satisfaction and meaning in activities as one purposefully attends to them.  In addition, all 
items in the acting with awareness subscale of the FFMQ reference being on autopilot.  
This state may be interpreted as emotional disengagement from important activities, 
which may be linked to distress. 
Increases in acting with awareness were also associated with decreased 
perceptions of sleep disturbance.  Cancer survivors who develop the skill of acting with 
awareness may notice that their daily activities are not as hindered by their sleep 
problems as previously thought.  Acting with awareness also involves conscious, 
deliberate actions, which may include health behaviors that help modulate sleep and 
emotional distress (e.g., regular exercise) (Speck, Courneya, Mâsse, Duval, & Schmitz, 
2010). 
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Acting with awareness was the only aspect of mindfulness to show a modest 
association with fatigue interference; correlations between other facets of mindfulness 
and fatigue interference were close to zero.  Given the sample size, statistical power may 
have been inadequate to detect the effect of acting with awareness on fatigue interference.  
One explanation for this effect is that cancer survivors may perceive that fatigue has less 
of an impact on their activities if they are able to fully attend to activities in the present 
moment.  Furthermore, as mentioned previously, all items in the acting with awareness 
subscale reference being “on autopilot,” which may be similar to the experience of 
fatigue.   
Increases in nonjudging were linked to decreased distress and sleep disturbance.  
Results are consistent with cross-sectional findings of negative associations between 
nonjudging and distress in a sample seeking mental health treatment, as well as general 
population samples with mixed levels of meditation experience (Baer et al., 2006; Cash 
& Whittingham, 2010; Desrosiers et al., 2013).  Findings are also consistent with prior 
research linking nonjudging to fewer ruminative thoughts that may exacerbate depression 
and distress (Baer, 2003; Nolen-Hoeksema et al., 2008).  Ruminative thoughts about 
insomnia are also positively related to sleep disturbance (Carney, Harris, Falco, & 
Edinger, 2013); thus, a more nonjudgmental attitude toward these thoughts may help 
lessen their impact on sleep.  This explanation is plausible, given the strong correlation 
between distress and the severity of sleep-wake disturbances in cancer populations (Otte 
et al., 2010; Palesh et al., 2010).   
Increased nonreactivity was also linked to decreased distress.  This relationship 
may be explained by the relaxation response.  By not being overly reactive to negative 
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cognitions and sensations, one may experience reduced sympathetic nervous system 
response (J. W. Hoffman et al., 1982), which, in turn, decreases arousal and physical 
tension, both of which lead to less distress.  In addition, stepping back from distressing 
thoughts, feelings, or images may allow an individual to simply notice them without 
being overwhelmed by them.  Previous literature has also demonstrated that attempts to 
avoid unpleasant cognitions and emotions (i.e., thought suppression) may have 
paradoxical rebound effects, resulting in stronger or more frequent unpleasant internal 
experiences (Abramowitz, Tolin, & Street, 2001).  Adopting a nonreactive stance towards 
such thoughts may reduce emotional avoidance and lead to decreases in distress. 
Despite MBSR’s large effects on fatigue interference in the parent trial, the only 
facet of mindfulness to have a modest association with fatigue interference was acting 
with awareness.  As noted previously, observing may not have been related to change in 
fatigue interference due to limitations in its measurement.  For example, observing had 
unexpected positive associations with maladaptive psychological characteristics in 
nonmeditating samples at the time of measure development (Baer et al., 2008).  Levels of 
describing in the present study were relatively high at baseline, which may help explain 
its lack of association with fatigue interference.  Nonjudging and nonreactivity may not 
be linked to changes in fatigue interference because this attitude towards fatigue does not 
necessarily mean that one will be able to carry out important activities with ease.  
Conversely, a person with high levels of acting with awareness is actively engaging in 
activities, which may reduce perceptions of fatigue interference.  Thus, the varying 
results at the facet level of mindfulness underscores the importance of assessing and 
specifically targeting mindfulness facets in future MBSR intervention studies. 
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Limitations, Strengths, and Implications 
Several limitations of the present study must be considered.  First, the sample size 
was limited for a RCT, which reduced statistical power for detecting effects.  In terms of 
design, MBSR was tested against a waitlist control group, which has limitations relative 
to an active comparator group.  Having an attention control group would enable the study 
of possible nonspecific factors (e.g., group context, instructor likeability, expectations for 
improvement) that influence the efficacy of the intervention, and may help determine 
whether development of mindfulness, acceptance, and self-compassion is limited to 
MBSR interventions.  Additionally, the current sample was relatively homogenous, 
consisting of primarily Caucasian women who had been diagnosed with early-stage 
breast cancer.  Thus, study findings may not generalize to men, ethnic minorities, and 
people with other cancer types and stages.  In terms of data collection, all the key 
variables were based on self-report measures, which can be susceptible to problems such 
as lack of construct validity, expectation and bias effects, social desirability, and lack of 
score sensitivity (Furr & Bacharach, 2013).  Also, caution must be demonstrated for the 
use of residualized change scores of mindfulness facets, as these scores may be less 
reliable than their constituent parts (Rogosa, Brandt, & Zimowski, 1982).  Residualized 
change scores also rely on the assumption that the final observed data is a linear function 
of the initial observed data, which may be problematic with outliers (Willett, 1988).  
Finally, reports of recent mental health treatment at baseline were significantly greater for 
the WC group as compared to the MBSR group (n = 7 vs. 1, respectively).  However, 
bivariate correlations between mental health treatment and key study variables at baseline 
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only revealed a significant correlation between this variable and acting with awareness, 
which did not differ between groups. 
This study has several notable strengths.  First, retention in this study was 
excellent, with 100% retention through the first follow-up time point.  Only one 
participant in the WC group did not complete the final assessment following the 
completion of the MBSR course.  Second, all participants had clinically meaningful 
levels of fatigue at study entry; thus, results may generalize to a cancer population with 
greater need for services.  Third, to my knowledge, this is the first study to analyze 
changes in individual facets of mindfulness across time as predictors of both physical and 
psychological symptom changes in a cancer population.  Given the popularity of 
mindfulness-based interventions for cancer patients and survivors, these results may help 
guide the development of future MBSR interventions for this population. 
Several directions for future research on MBSR in cancer survivors warrant 
consideration.  First, future studies should be conducted with larger sample sizes, an 
active comparator group, and more assessment time points over a longer period to expand 
and replicate these results.  A possible active comparator group for future studies with 
MBSR may be the Health Enhancement Program (HEP), which was designed to match 
several key characteristics of the MBSR course, such as course length and group context 
(MacCoon et al., 2012).  The length of HEP would need to be shortened in future studies 
if compared to this particular adaptation of MBSR for fatigued cancer survivors.  Formal 
mediation analyses should also be conducted to further assess the relationships between 
theory-based psychological processes thought to underlie MBSR and symptoms.  Given 
mixed results regarding relations between aspects of mindfulness and symptoms, future 
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research should also explore interactive effects of these aspects to more fully examine the 
contribution of each process in predicting symptom improvement.  In addition, studies 
may include assessment time points during the intervention to gain a better understanding 
of the temporal patterns of these psychological processes and how they relate to 
symptoms.   
Furthermore, MBSR curriculum in future studies may compare versions of the 
intervention that emphasize different psychological processes to identify the critical 
ingredients of the intervention.  Based on the current findings, future studies of MBSR 
may include more home practice assignments that target acting with awareness.  Findings 
also suggest that future studies should emphasize intervention components thought to 
target processes linked to reduced sleep disturbance and distress (i.e., observing, acting 
with awareness, nonjudging, and nonreactivity).  Although MBSR exercises theoretically 
impact all facets of mindfulness, some exercises may facilitate greater development of 
certain facets.  For example, being instructed to observe an object or scene may help 
develop the observing facet of mindfulness, but may not necessarily involve nonjudging 
or nonreactivity.  These facets of mindfulness may be more fully developed in exercises 
such as the body scan.  During this exercise, survivors are instructed to attend to different 
aspects of their body (e.g., surgically altered body parts) in a nonjudgmental way.  
Additionally, to develop the skill of acting with awareness, participants could be 
instructed to be fully present when engaging in an activity that is important to them, such 
as spending time with loved ones.   
Course adaptations to facilitate the development of specific facets of mindfulness 
could also be adjusted for participants, depending on their symptom presentation.  For 
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instance, emphasis on the aforementioned mindfulness processes could occur during 
didactics on sleep or distress if participants have high levels of either symptom.  Future 
studies may also examine MBSR in samples of varying characteristics, such as 
individuals who are male or those who have invasive or metastatic disease.  If researchers 
expand this line of work to other cancer populations and identify mechanisms underlying 
MBSR’s effects, clinicians will have a stronger evidence base for relieving the suffering 
of the ever-growing population of cancer survivors. 
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APPENDIX A. MEASURES 
Screening Questionnaire 
1. Are you 18 or older? 
a. No—Ineligible  
b. Yes—Continue interview 
 
2. Have you ever participated in a teacher-instructed class that was focused on 
mindfulness meditation (e.g., MBSR)? 
a. Yes—Ineligible  
b. No—Continue interview 
 
3. Have you had chemotherapy, radiation therapy, surgery, or a bone marrow or 
stem cell transplant within the past 3 months (those on hormonal therapies are 
okay)? 
a. Yes—Ineligible  
b. No—Continue interview 
 
4. Are you currently enrolled in Hospice care? 
[IF PATIENT DOESN’T KNOW WHAT HOSPICE IS SAY:  “It’s a program of care at 
home or in a hospital for persons who are quite ill, so it sounds like this doesn’t apply to 
you.” 
a. Yes—Ineligible  
b. No—Continue interview 
 
5. Fatigue is a common symptom for people who have been diagnosed with cancer. 
Have you felt tired or fatigued in the last week? 
a. No—Ineligible  
b. Yes—Continue interview 
 
6. Have you felt tired or fatigued for at least 8 weeks?  
a. No—Ineligible  
b. Yes—Continue interview 
 
7. I’d like to ask you three questions now about the severity of your fatigue. For 
each question, please rate the severity of your fatigue on an 11-point scale, with 0 
= not at all fatigued to 10 = as fatigued as you could be. 
 
a. Rate your level of fatigue on the day you felt most fatigued during the past 
week:   
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                0     1     2     3     4     5     6     7     8      9    10   
                          Not at all fatigued      As fatigued as I could be 
 
b. Rate your level of fatigue on the day you felt least fatigued during the past 
week: 
                                
                0     1     2     3     4     5     6     7     8      9    10   
                          Not at all fatigued      As fatigued as I could be 
 
c. Rate your level of fatigue on the average during the past week: 
                                
                0     1     2     3     4     5     6     7     8      9    10   
                          Not at all fatigued      As fatigued as I could be 
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Baseline and Follow-up Questionnaires  
 
Demographic Information 
 
1. Ethnicity (check  all that apply) 
 White 
  Black or African American 
 Asian 
 American Indian or Alaska Native 
 Native Hawaiian or Other Pacific Islander 
 Other_______________________ 
 
2. Hispanic, Spanish or Latino? 
Yes   No 
 
3. Date of birth _____/______/_______    
 
4. What is your highest level of education? 
1. Eighth grade or less 
2. Some high school 
3. High school graduate or GED 
4. Some college 
5. Technical or trade school 
6. College graduate 
7. Advanced graduate or professional degree 
8. Other _____________________ 
 
5. What is your current employment status?       
1. Employed for wages 
2. Self-employed 
             Part-time   Full-time 
3. Out of work for more than 1 year 
4. Out of work for less than 1 year 
5. Homemaker 
6. Student 
7. Retired 
8. Unable to work (health/disability) 
9. Other _______________________ 
 
6.  Gender:    Male  Female 
 
7. Marital Status:  
Married   Divorced 
Never married   
Widowed Separated 
Member of an unmarried couple 
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8. When you consider your household income from all sources today, would you say that 
you are comfortable, Have just enough to makes ends meet, or Do NOT have enough to 
make ends meet? 
 Comfortable 
  Just enough to make ends meet 
  NOT enough to make ends meet 
 
9. Please read the list of chronic health problems below. If a doctor or other health care 
worker has diagnosed you with or treated you for any of the following in the past 3 years, 
please check. 
 
 Asthma, emphysema, or chronic bronchitis 
 High blood pressure or hypertension 
 High blood sugar or diabetes 
 Arthritis or rheumatism (inflammation of the joints) 
 Angina, heart failure, or other types of heart disease 
 Strokes, seizures, Parkinson’s disease, or other neurological condition 
 Liver disease 
 Kidney or renal disease 
 Chronic Fatigue Syndrome 
 Fibromyalgia 
 Other _____________________ 
 
10. Are you currently (within previous 6 months) receiving treatment from a psychiatrist, 
psychotherapist, or other mental health worker? 
Yes   No 
 
11. If not, have your received treatment from a psychiatrist, psychotherapist, or other 
mental health worker in the past 5 years? 
 Yes   No 
 
12. Are you currently taking any of the following medications? 
 
Erythropoiesis-Stimulating Agents (ESAs), such as epoetin alfa (marketed as Procrit or 
Epogen), or darbepoetin alpha (marketed as Aranesp) 
Yes   No  
 
Psychostimulants, such as methylphenidate [Ritalin or Concerta], dextroamphetamine 
[Dexedrine], Adderall, Strattera 
Yes   No 
 
Prescription wakefulness-enhancing drugs such as modafinil (Provigil) or armodafinil 
(Nuvigil)  
Yes   No 
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Any prescription anti-anxiety medication 
Yes   No 
 
 Any prescription anti-depressant medications 
Yes   No 
 
 
Fatigue Symptom Inventory (FSI) 
 
For each of the following, circle the one number that best indicates how that item applies 
to you. 
 
1. Rate your level of fatigue on the day you felt most fatigued during the past week: 
 
0   1     2     3     4     5     6     7     8     9     10 
Not at all fatigued         As fatigued as I could be 
 
2. Rate your level of fatigue on the day you felt least fatigued during the past week: 
 
0   1     2     3     4     5     6     7     8     9     10 
Not at all fatigued         As fatigued as I could be 
 
3. Rate your level of fatigue on the average during the past week: 
 
0   1     2     3     4     5     6     7     8     9     10 
Not at all fatigued         As fatigued as I could be 
 
4. Rate your level of fatigue right now: 
 
0   1     2     3     4     5     6     7     8     9     10 
Not at all fatigued         As fatigued as I could be 
 
5. Rate how much, in the past week, fatigue interfered with your general level of activity: 
 
0  1     2     3     4     5     6     7     8     9     10 
No interference         Extreme interference 
 
6. Rate how much, in the past week, fatigue interfered with your ability to bathe and 
dress yourself: 
 
0  1     2     3     4     5     6     7     8     9     10 
No interference         Extreme interference 
 
7. Rate how much, in the past week, fatigue interfered with your normal work activity 
(includes both work outside the home and housework): 
 
0  1     2     3     4     5     6     7     8     9     10 
No interference         Extreme interference 
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8. Rate how much, in the past week, fatigue interfered with your ability to concentrate: 
 
0  1     2     3     4     5     6     7     8     9     10 
No interference         Extreme interference 
 
9. Rate how much, in the past week, fatigue interfered with your relations with other 
people: 
 
0  1     2     3     4     5     6     7     8     9     10 
No interference         Extreme interference 
 
10. Rate how much, in the past week, fatigue interfered with your enjoyment of life: 
 
0  1     2     3     4     5     6     7     8     9     10 
No interference         Extreme interference 
 
11. Rate how much, in the past week, fatigue interfered with your mood: 
 
0  1     2     3     4     5     6     7     8     9     10 
No interference         Extreme interference 
 
12. Indicate how many days, in the past week, you felt fatigued for any part of the day: 
 
0  1     2     3     4     5     6     7 
 
13. Rate how much of the day, on average, you felt fatigued in the past week: 
 
0  1     2     3     4     5     6     7     8     9     10 
None of the day         The entire day 
 
 
Insomnia Severity Index (ISI) 
 
For each answer, please CIRCLE the number that best describes your answer. 
Please rate the CURRENT (i.e., last 2 weeks) SEVERITY of insomnia problem(s). 
 
1. Difficulty falling asleep 
None Mild Moderate Severe Very severe 
0 1 2 3 4 
 
2. Difficulty staying asleep 
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None Mild Moderate Severe Very severe 
0 1 2 3 4 
 
3. Problem waking up too early 
None Mild Moderate Severe Very severe 
0 1 2 3 4 
 
4. How SATISFIED/DISSATISFIED are you with your CURRENT sleep pattern? 
Very satisfied Satisfied 
Moderately 
satisfied 
Dissatisfied 
Very 
dissatisfied 
0 1 2 3 4 
 
5. How NOTICEABLE to others do you think your sleep problem is in terms of 
impairing the quality of your life? 
Not noticeable 
at all 
A little Somewhat Much 
Very much 
noticeable 
0 1 2 3 4 
 
6. How WORRIED/DISTRESSED are you about your current sleep problems? 
Not at all A little Somewhat Much 
Very much 
worried 
0 1 2 3 4 
 
7. To what extent do you consider your sleep problem to INTERFERE with your daily 
functioning (e.g., daytime fatigue, mood, ability to function at work/daily chores, 
concentration, memory, mood, etc.) CURRENTLY? 
Not at all 
interfering 
A little Somewhat Much 
Very much 
interfering 
0 1 2 3 4 
 
 
Patient Health Questionnaire-8 (PHQ-8) 
Over the last 2 weeks, how often have you been bothered by any of the following 
problems? Read each item carefully, and circle your response. 
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a. Little interest or pleasure in doing things 
 
Not at all          Several days          More than half the days          Nearly every day 
 
b. Feeling down, depressed, or hopeless 
 
Not at all          Several days          More than half the days          Nearly every day 
 
c. Trouble falling asleep, staying asleep, or sleeping too much 
 
Not at all          Several days          More than half the days          Nearly every day 
 
d. Feeling tired or having little energy 
 
Not at all          Several days          More than half the days          Nearly every day 
 
e. Poor appetite or overeating 
 
Not at all          Several days          More than half the days          Nearly every day 
 
f. Feeling bad about yourself, feeling that you are a failure, or feeling that you have let 
yourself or your family down  
 
Not at all          Several days          More than half the days          Nearly every day 
 
g. Trouble concentrating on things such as reading the newspaper or watching television 
 
Not at all          Several days          More than half the days          Nearly every day 
 
h. Moving or speaking so slowly that other people could have noticed. Or being so 
fidgety or restless that you have been moving around a lot more than usual 
 
Not at all          Several days          More than half the days          Nearly every day 
 
 
Generalized Anxiety Disorder Scale (GAD-7) 
For each item, please CIRCLE the number that represents the best answer. 
Circle only one number. 
Over the last 2 weeks, how 
often have you been 
bothered by the following 
problems 
0 
Not at all 
1 
Several days 
2 
More than 
half the 
days 
3 
Nearly every 
day 
1. Feeling nervous, anxious, 
or on edge 
0 1 2 3 
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2. Not being able to stop or 
control worrying 
0 1 2 3 
3. Worrying too much about 
little things 
0 1 2 3 
4. Having trouble relaxing 
 
0 1 2 3 
5. Being so restless that it is 
hard to sit still 
0 1 2 3 
6. Becoming easily bored or 
irritable 
0 1 2 3 
7. Feeling afraid as if 
something awful might 
happen 
0 1 2 3 
 
 
Five-Facet Mindfulness Questionnaire (FFMQ) 
Please rate each of the following statements using the scale provided. Write the number 
in the blank that best describes YOUR OWN OPINION of what is GENERALLY TRUE 
FOR YOU. 
 
1. When I’m walking, I deliberately notice the sensations of my body moving. 
Never or very 
rarely true 
Rarely true Sometimes true Often true 
Very often or 
always true 
1 2 3 4 5 
 
2. I’m good at finding words to describe my feelings. 
Never or very 
rarely true 
Rarely true Sometimes true Often true 
Very often or 
always true 
1 2 3 4 5 
 
3. I criticize myself for having irrational or inappropriate emotions. 
Never or very 
rarely true 
Rarely true Sometimes true Often true 
Very often or 
always true 
1 2 3 4 5 
 
4. I perceive my feelings and emotions without having to react to them. 
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Never or very 
rarely true 
Rarely true Sometimes true Often true 
Very often or 
always true 
1 2 3 4 5 
 
5. When I do things, my mind wanders off and I’m easily distracted. 
Never or very 
rarely true 
Rarely true Sometimes true Often true 
Very often or 
always true 
1 2 3 4 5 
 
6. When I take a shower or bath, I stay alert to the sensations of water on my body. 
Never or very 
rarely true 
Rarely true Sometimes true Often true 
Very often or 
always true 
1 2 3 4 5 
 
7. I can easily put my beliefs, opinions, and expectations into words. 
Never or very 
rarely true 
Rarely true Sometimes true Often true 
Very often or 
always true 
1 2 3 4 5 
 
8. I don’t pay attention to what I’m doing because I’m daydreaming, worrying, or 
otherwise distracted. 
Never or very 
rarely true 
Rarely true Sometimes true Often true 
Very often or 
always true 
1 2 3 4 5 
 
9. I watch my feelings without getting lost in them. 
Never or very 
rarely true 
Rarely true Sometimes true Often true 
Very often or 
always true 
1 2 3 4 5 
 
10. I tell myself I shouldn’t be feeling the way I’m feelings. 
Never or very 
rarely true 
Rarely true Sometimes true Often true 
Very often or 
always true 
1 2 3 4 5 
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11. I notice how foods and drinks affect my thoughts, bodily sensations, and emotions. 
 
Never or very 
rarely true 
Rarely true Sometimes true Often true 
Very often or 
always true 
1 2 3 4 5 
 
12. It’s hard for me to find the words to describe what I’m thinking. 
Never or very 
rarely true 
Rarely true Sometimes true Often true 
Very often or 
always true 
1 2 3 4 5 
 
13. I am easily distracted. 
Never or very 
rarely true 
Rarely true Sometimes true Often true 
Very often or 
always true 
1 2 3 4 5 
  
14. I believe some of my thoughts are abnormal or bad and I shouldn’t think that way. 
Never or very 
rarely true 
Rarely true Sometimes true Often true 
Very often or 
always true 
1 2 3 4 5 
 
15. I pay attention to sensations, such as the wind in my hair or sun on my face. 
Never or very 
rarely true 
Rarely true Sometimes true Often true 
Very often or 
always true 
1 2 3 4 5 
 
16. I have trouble thinking of the right words to express how I feel about things. 
Never or very 
rarely true 
Rarely true Sometimes true Often true 
Very often or 
always true 
1 2 3 4 5 
 
17. I make judgments about whether my thoughts are good or bad. 
Never or very 
rarely true 
Rarely true Sometimes true Often true 
Very often or 
always true 
1 2 3 4 5 
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18. I find it difficult to stay focused on what’s happening in the present. 
Never or very 
rarely true 
Rarely true Sometimes true Often true 
Very often or 
always true 
1 2 3 4 5 
 
19.  When I have distressing thoughts or images, I “step back” and am aware of the 
thought or image without getting taken over by it. 
Never or very 
rarely true 
Rarely true Sometimes true Often true 
Very often or 
always true 
1 2 3 4 5 
 
20. I pay attention to sounds, such as clocks ticking, birds chirping, or cars passing. 
Never or very 
rarely true 
Rarely true Sometimes true Often true 
Very often or 
always true 
1 2 3 4 5 
 
21. In difficult situations, I can pause without immediately reacting. 
Never or very 
rarely true 
Rarely true Sometimes true Often true 
Very often or 
always true 
1 2 3 4 5 
 
22. When I have a sensation in my body, it’s difficult for me to describe it because I can’t 
find the right words. 
Never or very 
rarely true 
Rarely true Sometimes true Often true 
Very often or 
always true 
1 2 3 4 5 
 
23. It seems I am “running on automatic” without much awareness of what I’m doing. 
Never or very 
rarely true 
Rarely true Sometimes true Often true 
Very often or 
always true 
1 2 3 4 5 
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24. When I have distressing thoughts or images, I feel calm soon after. 
Never or very 
rarely true 
Rarely true Sometimes true Often true 
Very often or 
always true 
1 2 3 4 5 
 
25. I tell myself that I shouldn’t be thinking the way I’m thinking. 
Never or very 
rarely true 
Rarely true Sometimes true Often true 
Very often or 
always true 
1 2 3 4 5 
 
26. I notice the smells and aromas of things. 
Never or very 
rarely true 
Rarely true Sometimes true Often true 
Very often or 
always true 
1 2 3 4 5 
 
27. Even when I’m feeling terribly upset, I can find a way to put it into words. 
Never or very 
rarely true 
Rarely true Sometimes true Often true 
Very often or 
always true 
1 2 3 4 5 
 
28. I rush through activities without being really attentive to them. 
Never or very 
rarely true 
Rarely true Sometimes true Often true 
Very often or 
always true 
1 2 3 4 5 
 
29. When I have distressing thoughts or images I am able just to notice them without 
reacting. 
Never or very 
rarely true 
Rarely true Sometimes true Often true 
Very often or 
always true 
1 2 3 4 5 
 
30. I think some of my emotions are bad or inappropriate and I shouldn’t feel them. 
Never or very 
rarely true 
Rarely true Sometimes true Often true 
Very often or 
always true 
1 2 3 4 5 
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31. I notice visual elements in art or nature, such as colors, shapes, textures, or patterns of 
light and shadow. 
Never or very 
rarely true 
Rarely true Sometimes true Often true 
Very often or 
always true 
1 2 3 4 5 
 
32. My natural tendency is to put my experiences into words. 
Never or very 
rarely true 
Rarely true Sometimes true Often true 
Very often or 
always true 
1 2 3 4 5 
 
33. When I have distressing thoughts or images, I just notice them and let them go. 
Never or very 
rarely true 
Rarely true Sometimes true Often true 
Very often or 
always true 
1 2 3 4 5 
 
34. I do jobs or tasks automatically without being aware of what I’m doing. 
Never or very 
rarely true 
Rarely true Sometimes true Often true 
Very often or 
always true 
1 2 3 4 5 
 
35. When I have distressing thoughts or images, I judge myself as good or bad, 
depending on what the thought/image is about. 
Never or very 
rarely true 
Rarely true Sometimes true Often true 
Very often or 
always true 
1 2 3 4 5 
 
36. I pay attention to how my emotions affect my thoughts and behaviors. 
Never or very 
rarely true 
Rarely true Sometimes true Often true 
Very often or 
always true 
1 2 3 4 5 
 
37. I can usually describe how I feel at the moment in considerable detail. 
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Never or very 
rarely true 
Rarely true Sometimes true Often true 
Very often or 
always true 
1 2 3 4 5 
 
38. I find myself doing things without paying attention. 
Never or very 
rarely true 
Rarely true Sometimes true Often true 
Very often or 
always true 
1 2 3 4 5 
 
39. I disapprove of myself when I have irrational ideas. 
Never or very 
rarely true 
Rarely true Sometimes true Often true 
Very often or 
always true 
1 2 3 4 5 
 
 
Acceptance and Action Questionnaire (AAQ-II) 
 
Below you will find a list of statements. Please rate how true each statement is for you by 
circling a number next to it. Use the scale below to make your choice.  
 
1 2 3 4 5 6 7 
never 
 true 
very seldom 
true 
seldom  
true 
sometimes  
true 
frequently  
true 
almost 
always true 
always  
true 
       
1. It’s okay if I remember something unpleasant. 1 2 3 4 5 6 7 
2. My painful experiences and memories make it difficult for me 
to live a life that I would value. 
1 2 3 4 5 6 7 
3. I’m afraid of my feelings. 1 2 3 4 5 6 7 
4. I worry about not being able to control my worries and feelings. 1 2 3 4 5 6 7 
5. My painful memories prevent me from having a fulfilling life. 1 2 3 4 5 6 7 
6. I am in control of my life. 1 2 3 4 5 6 7 
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7. Emotions cause problems in my life. 1 2 3 4 5 6 7 
8. It seems like most people are handling their lives better than I 
am. 
1 2 3 4 5 6 7 
9. Worries get in the way of my success. 1 2 3 4 5 6 7 
10. My thoughts and feelings do not get in the way of how I want to 
live my life. 
1 2 3 4 5 6 7 
 
 
Self-Compassion Scale-Short Form (SCS-SF) 
Please read each statement carefully before answering. To the left of each item, indicate 
how often you behave in the stated manner, using the following scale: 
Almost        Almost 
Never         Always 
1                        2                        3                        4                        5 
 
_____  1. When I fail at something important to me I become consumed by feelings of 
inadequacy.  
_____  2. I try to be understanding and patient towards those aspects of my personality I 
don’t like.  
_____  3. When something painful happens I try to take a balanced view of the situation.  
_____  4. When I’m feeling down, I tend to feel like most other people are probably 
happier than I am.  
_____  5. I try to see my failings as part of the human condition.  
_____  6. When I’m going through a very hard time, I give myself the caring and 
tenderness I need.  
_____  7. When something upsets me I try to keep my emotions in balance.  
_____  8. When I fail at something that’s important to me, I tend to feel alone in my 
failure.  
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_____  9. When I’m feeling down I tend to obsess and fixate on everything that’s wrong.  
_____  10. When I feel inadequate in some way, I try to remind myself that feelings of  
inadequacy are shared by most people.  
_____  11. I’m disapproving and judgmental about my own flaws and inadequacies.  
_____  12. I’m intolerant and impatient towards those aspects of my personality I don’t 
like. 
